primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
157526523,15752652,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG / 0.5 ML, UNK",,,,,,,,1.5,MG,,,2019,Q1,Pharyngitis streptococcal,,2019,Q1,3,F,201812.0,20190114.0,20181221,20190115,PER,,US-BEH-2018097799,CSL BEHRING,,63.0,YR,A,F,Y,,,20190115.0,,OT,US,US,2019,Q1,Adult
157526523,15752652,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG / 0.5 ML, UNK",,,,,,,,1.5,MG,,,2019,Q1,Pyrexia,,2019,Q1,3,F,201812.0,20190114.0,20181221,20190115,PER,,US-BEH-2018097799,CSL BEHRING,,63.0,YR,A,F,Y,,,20190115.0,,OT,US,US,2019,Q1,Adult
157714712,15771471,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,/wk,2019,Q1,Decreased activity,,2019,Q1,2,F,,20190124.0,20181228,20190131,EXP,,US-ROCHE-2234715,ROCHE,,43.0,YR,,M,Y,105.78,KG,20190131.0,,PH,US,US,2019,Q1,Adult
157714712,15771471,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,/wk,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,2,F,,20190124.0,20181228,20190131,EXP,,US-ROCHE-2234715,ROCHE,,43.0,YR,,M,Y,105.78,KG,20190131.0,,PH,US,US,2019,Q1,Adult
157714712,15771471,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,/wk,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,2,F,,20190124.0,20181228,20190131,EXP,,US-ROCHE-2234715,ROCHE,,43.0,YR,,M,Y,105.78,KG,20190131.0,,PH,US,US,2019,Q1,Adult
157714712,15771471,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.75,MG,,/wk,2019,Q1,Weight increased,,2019,Q1,2,F,,20190124.0,20181228,20190131,EXP,,US-ROCHE-2234715,ROCHE,,43.0,YR,,M,Y,105.78,KG,20190131.0,,PH,US,US,2019,Q1,Adult
158776281,15877628,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20180903.0,20190113.0,20190128,20190128,EXP,FR-AFSSAPS-ST20190003,FR-ZYDUS-032864,ZYDUS PHARM,,45.0,YR,,M,Y,92.0,KG,20190128.0,,MD,FR,FR,2019,Q1,Adult
158776281,15877628,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q1,Ketonuria,,2019,Q1,1,I,20180903.0,20190113.0,20190128,20190128,EXP,FR-AFSSAPS-ST20190003,FR-ZYDUS-032864,ZYDUS PHARM,,45.0,YR,,M,Y,92.0,KG,20190128.0,,MD,FR,FR,2019,Q1,Adult
158776281,15877628,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q1,Vomiting,,2019,Q1,1,I,20180903.0,20190113.0,20190128,20190128,EXP,FR-AFSSAPS-ST20190003,FR-ZYDUS-032864,ZYDUS PHARM,,45.0,YR,,M,Y,92.0,KG,20190128.0,,MD,FR,FR,2019,Q1,Adult
158975701,15897570,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Blindness unilateral,,2019,Q1,1,I,,20190125.0,20190131,20190131,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201901013147,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20190131.0,,CN,FR,FR,2019,Q1,Elderly
158975701,15897570,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Glioblastoma,,2019,Q1,1,I,,20190125.0,20190131,20190131,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201901013147,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20190131.0,,CN,FR,FR,2019,Q1,Elderly
158975701,15897570,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Headache,,2019,Q1,1,I,,20190125.0,20190131,20190131,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201901013147,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20190131.0,,CN,FR,FR,2019,Q1,Elderly
158975701,15897570,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Neuralgia,,2019,Q1,1,I,,20190125.0,20190131,20190131,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201901013147,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20190131.0,,CN,FR,FR,2019,Q1,Elderly
158975701,15897570,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Visual acuity reduced,,2019,Q1,1,I,,20190125.0,20190131,20190131,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201901013147,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20190131.0,,CN,FR,FR,2019,Q1,Elderly
159170861,15917086,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,DF,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,20180615.0,20190125.0,20190205,20190205,EXP,FR-AFSSAPS-AM20190089,FR-ZYDUS-033110,ZYDUS PHARM,,71.0,YR,,M,Y,91.0,KG,20190205.0,,MD,FR,FR,2019,Q1,Elderly
159170861,15917086,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,DF,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20180615.0,20190125.0,20190205,20190205,EXP,FR-AFSSAPS-AM20190089,FR-ZYDUS-033110,ZYDUS PHARM,,71.0,YR,,M,Y,91.0,KG,20190205.0,,MD,FR,FR,2019,Q1,Elderly
159170861,15917086,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,DF,,,2019,Q1,Hyperkalaemia,,2019,Q1,1,I,20180615.0,20190125.0,20190205,20190205,EXP,FR-AFSSAPS-AM20190089,FR-ZYDUS-033110,ZYDUS PHARM,,71.0,YR,,M,Y,91.0,KG,20190205.0,,MD,FR,FR,2019,Q1,Elderly
159170861,15917086,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,DF,,,2019,Q1,Metabolic acidosis,,2019,Q1,1,I,20180615.0,20190125.0,20190205,20190205,EXP,FR-AFSSAPS-AM20190089,FR-ZYDUS-033110,ZYDUS PHARM,,71.0,YR,,M,Y,91.0,KG,20190205.0,,MD,FR,FR,2019,Q1,Elderly
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Cerebral infarction,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Dehydration,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Nausea,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Papilloedema,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Tachycardia,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Transverse sinus thrombosis,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, WEEKLY (1/W)",,,U,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Vomiting,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Cerebral infarction,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Dehydration,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Nausea,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Papilloedema,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Tachycardia,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Transverse sinus thrombosis,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159291462,15929146,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,U,U,,,125469.0,1.5,MG,,/wk,2019,Q1,Vomiting,,2019,Q1,2,F,,20190207.0,20190206,20190218,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901014714,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20190218.0,,OT,IN,IN,2019,Q1,Adult
159457902,15945790,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DF, QWK",2.0,DF,Y,, UNKNOWN,,,1.0,DF,INJECTION,/wk,2019,Q1,Acute kidney injury,,2019,Q1,2,F,20180615.0,20190313.0,20190211,20190326,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-013861,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,91.0,KG,20190326.0,,MD,FR,FR,2019,Q1,Elderly
159457902,15945790,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DF, QWK",2.0,DF,Y,, UNKNOWN,,,1.0,DF,INJECTION,/wk,2019,Q1,Diarrhoea,,2019,Q1,2,F,20180615.0,20190313.0,20190211,20190326,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-013861,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,91.0,KG,20190326.0,,MD,FR,FR,2019,Q1,Elderly
159457902,15945790,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DF, QWK",2.0,DF,Y,, UNKNOWN,,,1.0,DF,INJECTION,/wk,2019,Q1,Hyperkalaemia,,2019,Q1,2,F,20180615.0,20190313.0,20190211,20190326,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-013861,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,91.0,KG,20190326.0,,MD,FR,FR,2019,Q1,Elderly
159457902,15945790,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1 DF, QWK",2.0,DF,Y,, UNKNOWN,,,1.0,DF,INJECTION,/wk,2019,Q1,Metabolic acidosis,,2019,Q1,2,F,20180615.0,20190313.0,20190211,20190326,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-013861,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,91.0,KG,20190326.0,,MD,FR,FR,2019,Q1,Elderly
159498741,15949874,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q1,Blindness unilateral,,2019,Q1,1,I,201805.0,20190207.0,20190211,20190211,EXP,,FR-PFIZER INC-2019061415,PFIZER,,67.0,YR,,M,Y,,,20190211.0,,CN,FR,FR,2019,Q1,Elderly
159498741,15949874,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q1,Glioblastoma,,2019,Q1,1,I,201805.0,20190207.0,20190211,20190211,EXP,,FR-PFIZER INC-2019061415,PFIZER,,67.0,YR,,M,Y,,,20190211.0,,CN,FR,FR,2019,Q1,Elderly
159498741,15949874,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q1,Headache,,2019,Q1,1,I,201805.0,20190207.0,20190211,20190211,EXP,,FR-PFIZER INC-2019061415,PFIZER,,67.0,YR,,M,Y,,,20190211.0,,CN,FR,FR,2019,Q1,Elderly
159498741,15949874,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q1,Neuralgia,,2019,Q1,1,I,201805.0,20190207.0,20190211,20190211,EXP,,FR-PFIZER INC-2019061415,PFIZER,,67.0,YR,,M,Y,,,20190211.0,,CN,FR,FR,2019,Q1,Elderly
159498741,15949874,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q1,Visual acuity reduced,,2019,Q1,1,I,201805.0,20190207.0,20190211,20190211,EXP,,FR-PFIZER INC-2019061415,PFIZER,,67.0,YR,,M,Y,,,20190211.0,,CN,FR,FR,2019,Q1,Elderly
159553791,15955379,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,N,,,,,1.5,MG,,,2019,Q1,Hyperamylasaemia,,2019,Q1,1,I,20170905.0,20190131.0,20190213,20190213,EXP,ES-AEMPS-362747,ES-ACCORD-106924,ACCORD,,53.0,YR,A,M,Y,,,20190213.0,,MD,ES,ES,2019,Q1,Adult
159553791,15955379,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,N,,,,,1.5,MG,,,2019,Q1,Lipase increased,,2019,Q1,1,I,20170905.0,20190131.0,20190213,20190213,EXP,ES-AEMPS-362747,ES-ACCORD-106924,ACCORD,,53.0,YR,A,M,Y,,,20190213.0,,MD,ES,ES,2019,Q1,Adult
159566392,15956639,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION,/wk,2019,Q1,Decreased appetite,,2019,Q1,2,F,20171016.0,20190221.0,20190213,20190301,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201902003420,ELI LILLY AND CO,,49.0,YR,,F,Y,57.0,KG,20190301.0,,MD,KR,KR,2019,Q1,Adult
159566392,15956639,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION,/wk,2019,Q1,Nausea,,2019,Q1,2,F,20171016.0,20190221.0,20190213,20190301,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201902003420,ELI LILLY AND CO,,49.0,YR,,F,Y,57.0,KG,20190301.0,,MD,KR,KR,2019,Q1,Adult
159566392,15956639,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION,/wk,2019,Q1,Urinary tract infection,,2019,Q1,2,F,20171016.0,20190221.0,20190213,20190301,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201902003420,ELI LILLY AND CO,,49.0,YR,,F,Y,57.0,KG,20190301.0,,MD,KR,KR,2019,Q1,Adult
159566392,15956639,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",,,,,,,125469.0,1.5,MG,SOLUTION FOR INJECTION,/wk,2019,Q1,Vomiting,,2019,Q1,2,F,20171016.0,20190221.0,20190213,20190301,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201902003420,ELI LILLY AND CO,,49.0,YR,,F,Y,57.0,KG,20190301.0,,MD,KR,KR,2019,Q1,Adult
159621081,15962108,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:ONCE A WEEK;?,,,Y,D,,,,1.5,MG,,QW,2019,Q1,Diarrhoea,,2019,Q1,1,I,20190112.0,,20190214,20190214,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20190214.0,N,PH,US,US,2019,Q1,Elderly
159744872,15974487,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY, SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q1,Product use issue,,2019,Q1,2,F,20190120.0,20190218.0,20190218,20190228,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,49.0,YR,A,F,Y,,,20190228.0,,CN,AE,AE,2019,Q1,Adult
159744872,15974487,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY, SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q1,Tendon rupture,,2019,Q1,2,F,20190120.0,20190218.0,20190218,20190228,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,49.0,YR,A,F,Y,,,20190228.0,,CN,AE,AE,2019,Q1,Adult
159794281,15979428,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20181113.0,,20190124,20190124,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20190118.0,N,PH,US,US,2019,Q1,Elderly
159794281,15979428,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Nausea,,2019,Q1,1,I,20181113.0,,20190124,20190124,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20190118.0,N,PH,US,US,2019,Q1,Elderly
159794281,15979428,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Vomiting,,2019,Q1,1,I,20181113.0,,20190124,20190124,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,20190118.0,N,PH,US,US,2019,Q1,Elderly
160133201,16013320,2,C,Dulaglutide (Trulicity) 1.5 mg SC Weekly,,2,,,,,,,,,,,,,,2019,Q1,Anion gap increased,,2019,Q1,1,I,20190225.0,,20190227,20190227,DIR,,,FDA-CTU,,65.0,YR,,F,N,89.0,KG,20190227.0,N,PH,US,US,2019,Q1,Elderly
160133201,16013320,2,C,Dulaglutide (Trulicity) 1.5 mg SC Weekly,,2,,,,,,,,,,,,,,2019,Q1,Atrial fibrillation,,2019,Q1,1,I,20190225.0,,20190227,20190227,DIR,,,FDA-CTU,,65.0,YR,,F,N,89.0,KG,20190227.0,N,PH,US,US,2019,Q1,Elderly
160133201,16013320,2,C,Dulaglutide (Trulicity) 1.5 mg SC Weekly,,2,,,,,,,,,,,,,,2019,Q1,Dehydration,,2019,Q1,1,I,20190225.0,,20190227,20190227,DIR,,,FDA-CTU,,65.0,YR,,F,N,89.0,KG,20190227.0,N,PH,US,US,2019,Q1,Elderly
160133201,16013320,2,C,Dulaglutide (Trulicity) 1.5 mg SC Weekly,,2,,,,,,,,,,,,,,2019,Q1,Nausea,,2019,Q1,1,I,20190225.0,,20190227,20190227,DIR,,,FDA-CTU,,65.0,YR,,F,N,89.0,KG,20190227.0,N,PH,US,US,2019,Q1,Elderly
160133201,16013320,2,C,Dulaglutide (Trulicity) 1.5 mg SC Weekly,,2,,,,,,,,,,,,,,2019,Q1,Vomiting,,2019,Q1,1,I,20190225.0,,20190227,20190227,DIR,,,FDA-CTU,,65.0,YR,,F,N,89.0,KG,20190227.0,N,PH,US,US,2019,Q1,Elderly
160280781,16028078,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q1,Headache,,2019,Q1,1,I,20181213.0,20190225.0,20190304,20190304,EXP,GB-MHRA-EYC 00194853,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-000711",BOEHRINGER INGELHEIM,,43.0,YR,,M,Y,143.0,KG,20190304.0,,CN,GB,GB,2019,Q1,Adult
160821191,16082119,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q1,Euglycaemic diabetic ketoacidosis,,2019,Q1,1,I,20190131.0,20190315.0,20190317,20190317,EXP,GB-MHRA-EYC 00196030,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-000898",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,68.5,KG,20190318.0,,PH,GB,GB,2019,Q1,Adult
160861041,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Dermatitis allergic,,2019,Q1,1,I,201902.0,20190308.0,20190318,20190318,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190318.0,,CN,GB,GB,2019,Q1,Adult
160861041,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Swelling face,,2019,Q1,1,I,201902.0,20190308.0,20190318,20190318,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190318.0,,CN,GB,GB,2019,Q1,Adult
160861041,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q1,Swollen tongue,,2019,Q1,1,I,201902.0,20190308.0,20190318,20190318,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190318.0,,CN,GB,GB,2019,Q1,Adult
161173171,16117317,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Abdominal pain,,2019,Q1,1,I,20181211.0,,20190221,20190221,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20190215.0,N,PH,US,US,2019,Q1,Adult
161173171,16117317,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20181211.0,,20190221,20190221,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20190215.0,N,PH,US,US,2019,Q1,Adult
161173171,16117317,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Dyspepsia,,2019,Q1,1,I,20181211.0,,20190221,20190221,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20190215.0,N,PH,US,US,2019,Q1,Adult
161173171,16117317,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Pancreatitis,,2019,Q1,1,I,20181211.0,,20190221,20190221,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20190215.0,N,PH,US,US,2019,Q1,Adult
161173171,16117317,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,Y,D,,,,,,,,2019,Q1,Vomiting,,2019,Q1,1,I,20181211.0,,20190221,20190221,DIR,,,FDA-CTU,,52.0,YR,,M,N,,,20190215.0,N,PH,US,US,2019,Q1,Adult
136540955,13654095,28,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,D,,,,,0.75,MG,UNSPECIFIED,/wk,2019,Q2,Salmonellosis,,2019,Q2,5,F,20161116.0,20190327.0,20170614,20190401,EXP,,US-JNJFOC-20170124230,JANSSEN,,61.0,YR,A,F,Y,,,20190401.0,,MD,US,US,2019,Q2,Adult
153497012,15349701,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",18.0,MG,,,,,,1.5,MG,,/wk,2019,Q2,Pancreatic carcinoma,,2019,Q2,2,F,20160414.0,20190430.0,20180904,20190513,EXP,,US-NOVOPROD-618499,NOVO NORDISK,,63.0,YR,,F,Y,94.79,KG,20190513.0,,LW,US,US,2019,Q2,Adult
153497012,15349701,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",18.0,MG,,,,,,1.5,MG,,/wk,2019,Q2,Pancreatitis,,2019,Q2,2,F,20160414.0,20190430.0,20180904,20190513,EXP,,US-NOVOPROD-618499,NOVO NORDISK,,63.0,YR,,F,Y,94.79,KG,20190513.0,,LW,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Catheterisation cardiac,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Chest pain,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Death,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Headache,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
159744873,15974487,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QWK SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q2,Drug ineffective,,2019,Q2,3,F,20170912.0,20190611.0,20190218,20190620,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,48.0,YR,A,F,Y,,,20190620.0,,OT,AE,AE,2019,Q2,Adult
159744873,15974487,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QWK SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q2,Off label use,,2019,Q2,3,F,20170912.0,20190611.0,20190218,20190620,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,48.0,YR,A,F,Y,,,20190620.0,,OT,AE,AE,2019,Q2,Adult
159744873,15974487,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QWK SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q2,Product use issue,,2019,Q2,3,F,20170912.0,20190611.0,20190218,20190620,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,48.0,YR,A,F,Y,,,20190620.0,,OT,AE,AE,2019,Q2,Adult
159744873,15974487,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QWK SINCE 3 MONTHS",,,,,,,,1.5,MG,,/wk,2019,Q2,Tendon rupture,,2019,Q2,3,F,20170912.0,20190611.0,20190218,20190620,EXP,,AE-AMGEN-ARESP2019012271,AMGEN,,48.0,YR,A,F,Y,,,20190620.0,,OT,AE,AE,2019,Q2,Adult
159953722,15995372,21,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,2,F,20150728.0,20190624.0,20190222,20190626,EXP,,US-PFIZER INC-2019082144,PFIZER,,74.0,YR,,M,Y,,,20190626.0,,LW,US,US,2019,Q2,Elderly
160125472,16012547,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Portal vein thrombosis,,2019,Q2,2,F,20181124.0,20190417.0,20190227,20190604,PER,,US-DOVA PHARMACEUTICALS INC.-DOV-000242,DOVA PHARMACEUTICALS,,63.0,YR,,F,Y,105.21,KG,20190604.0,,CN,US,US,2019,Q2,Adult
160861042,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q2,Dermatitis allergic,,2019,Q2,2,F,201902.0,20190308.0,20190318,20190528,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190528.0,,CN,GB,GB,2019,Q2,Adult
160861042,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q2,Swelling face,,2019,Q2,2,F,201902.0,20190308.0,20190318,20190528,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190528.0,,CN,GB,GB,2019,Q2,Adult
160861042,16086104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,0.857,MG,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q2,Swollen tongue,,2019,Q2,2,F,201902.0,20190308.0,20190318,20190528,EXP,GB-MHRA-EYC 00195454,GB-ELI_LILLY_AND_COMPANY-GB201903005049,ELI LILLY AND CO,,62.0,YR,,M,Y,106.0,KG,20190528.0,,CN,GB,GB,2019,Q2,Adult
161271821,16127182,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:ONCE WEEKLY;?,,,Y,D,,,,1.5,MG,,,2019,Q2,Erythema,,2019,Q2,1,I,20190228.0,,20190327,20190327,DIR,,,FDA-CTU,,74.0,YR,,F,N,,,20190327.0,N,PH,US,US,2019,Q2,Elderly
161271821,16127182,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:ONCE WEEKLY;?,,,Y,D,,,,1.5,MG,,,2019,Q2,Pruritus,,2019,Q2,1,I,20190228.0,,20190327,20190327,DIR,,,FDA-CTU,,74.0,YR,,F,N,,,20190327.0,N,PH,US,US,2019,Q2,Elderly
161438421,16143842,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,USE AS DIRECTED,,,D,,,,,,,UNSPECIFIED,,2019,Q2,Diabetic ketoacidosis,,2019,Q2,1,I,20190311.0,20190328.0,20190401,20190401,EXP,GB-MHRA-TPP7612978C3787326YC1552330928908,GB-JNJFOC-20190342592,JANSSEN,,64.0,YR,A,M,Y,74.0,KG,20190401.0,,MD,GB,GB,2019,Q2,Adult
161473771,16147377,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q2,Anaphylactic reaction,,2019,Q2,1,I,,20190326.0,20190402,20190402,EXP,GB-MHRA-EYC 00196649,GB-ELI_LILLY_AND_COMPANY-GB201903014323,ELI LILLY AND CO,,69.0,YR,,M,Y,85.0,KG,20190402.0,,CN,GB,GB,2019,Q2,Elderly
161518022,16151802,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Colonic abscess,,2019,Q2,2,F,20190208.0,20190329.0,20190403,20190404,EXP,,US-EXELIXIS-XL18418019836,EXELIXIS,,53.0,YR,,F,Y,114.5,KG,20190404.0,,MD,US,US,2019,Q2,Adult
161518022,16151802,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Pneumonitis,,2019,Q2,2,F,20190208.0,20190329.0,20190403,20190404,EXP,,US-EXELIXIS-XL18418019836,EXELIXIS,,53.0,YR,,F,Y,114.5,KG,20190404.0,,MD,US,US,2019,Q2,Adult
161518022,16151802,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,2,F,20190208.0,20190329.0,20190403,20190404,EXP,,US-EXELIXIS-XL18418019836,EXELIXIS,,53.0,YR,,F,Y,114.5,KG,20190404.0,,MD,US,US,2019,Q2,Adult
161629911,16162991,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,1,I,20190311.0,20190403.0,20190405,20190405,EXP,GB-MHRA-EYC 00196895,GB-SA-2019SA093643,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190405.0,,PH,GB,GB,2019,Q2,Adult
161629911,16162991,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,1,I,20190311.0,20190403.0,20190405,20190405,EXP,GB-MHRA-EYC 00196895,GB-SA-2019SA093643,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190405.0,,PH,GB,GB,2019,Q2,Adult
161629911,16162991,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190311.0,20190403.0,20190405,20190405,EXP,GB-MHRA-EYC 00196895,GB-SA-2019SA093643,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190405.0,,PH,GB,GB,2019,Q2,Adult
161629911,16162991,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q2,Vomiting,,2019,Q2,1,I,20190311.0,20190403.0,20190405,20190405,EXP,GB-MHRA-EYC 00196895,GB-SA-2019SA093643,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190405.0,,PH,GB,GB,2019,Q2,Adult
161845341,16184534,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,1,I,20190311.0,20190408.0,20190411,20190411,EXP,GB-MHRA-EYC 00196895,GB-TAKEDA-2019TEU003948,TAKEDA,,45.0,YR,,F,Y,,,20190411.0,,OT,GB,GB,2019,Q2,Adult
161845341,16184534,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,1,I,20190311.0,20190408.0,20190411,20190411,EXP,GB-MHRA-EYC 00196895,GB-TAKEDA-2019TEU003948,TAKEDA,,45.0,YR,,F,Y,,,20190411.0,,OT,GB,GB,2019,Q2,Adult
161845341,16184534,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190311.0,20190408.0,20190411,20190411,EXP,GB-MHRA-EYC 00196895,GB-TAKEDA-2019TEU003948,TAKEDA,,45.0,YR,,F,Y,,,20190411.0,,OT,GB,GB,2019,Q2,Adult
161845341,16184534,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Vomiting,,2019,Q2,1,I,20190311.0,20190408.0,20190411,20190411,EXP,GB-MHRA-EYC 00196895,GB-TAKEDA-2019TEU003948,TAKEDA,,45.0,YR,,F,Y,,,20190411.0,,OT,GB,GB,2019,Q2,Adult
162003761,16200376,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,U,,,,,,,,2019,Q2,Joint dislocation,,2019,Q2,1,I,20180801.0,20190405.0,20190416,20190416,EXP,,CO-UCBSA-2019015227,UCB,,76.0,YR,,F,Y,64.0,KG,20190416.0,,CN,CO,CO,2019,Q2,Elderly
162243172,16224317,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intravenous (not otherwise specified),EVERY TUESDAY,,,,,,,,1.5,MG,,/wk,2019,Q2,Condition aggravated,,2019,Q2,2,F,20190108.0,20190416.0,20190422,20190424,EXP,,DE-GILEAD-2019-0403538,GILEAD,,66.0,YR,E,F,Y,99.0,KG,20190424.0,,MD,DE,DE,2019,Q2,Elderly
162243172,16224317,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intravenous (not otherwise specified),EVERY TUESDAY,,,,,,,,1.5,MG,,/wk,2019,Q2,Glomerular filtration rate decreased,,2019,Q2,2,F,20190108.0,20190416.0,20190422,20190424,EXP,,DE-GILEAD-2019-0403538,GILEAD,,66.0,YR,E,F,Y,99.0,KG,20190424.0,,MD,DE,DE,2019,Q2,Elderly
162243172,16224317,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intravenous (not otherwise specified),EVERY TUESDAY,,,,,,,,1.5,MG,,/wk,2019,Q2,Renal impairment,,2019,Q2,2,F,20190108.0,20190416.0,20190422,20190424,EXP,,DE-GILEAD-2019-0403538,GILEAD,,66.0,YR,E,F,Y,99.0,KG,20190424.0,,MD,DE,DE,2019,Q2,Elderly
162243172,16224317,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intravenous (not otherwise specified),EVERY TUESDAY,,,,,,,,1.5,MG,,/wk,2019,Q2,Underdose,,2019,Q2,2,F,20190108.0,20190416.0,20190422,20190424,EXP,,DE-GILEAD-2019-0403538,GILEAD,,66.0,YR,E,F,Y,99.0,KG,20190424.0,,MD,DE,DE,2019,Q2,Elderly
162437972,16243797,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, Q.WK.",,,U,U,,,,7.5,MG,,/wk,2019,Q2,Colitis,,2019,Q2,2,F,,20190424.0,20190426,20190506,EXP,,CA-APOTEX-2019AP012426,APOTEX,,73.0,YR,,F,Y,,,20190506.0,,CN,CA,CA,2019,Q2,Elderly
162437972,16243797,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, Q.WK.",,,U,U,,,,7.5,MG,,/wk,2019,Q2,Colitis ulcerative,,2019,Q2,2,F,,20190424.0,20190426,20190506,EXP,,CA-APOTEX-2019AP012426,APOTEX,,73.0,YR,,F,Y,,,20190506.0,,CN,CA,CA,2019,Q2,Elderly
162437972,16243797,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, Q.WK.",,,U,U,,,,7.5,MG,,/wk,2019,Q2,Decreased activity,,2019,Q2,2,F,,20190424.0,20190426,20190506,EXP,,CA-APOTEX-2019AP012426,APOTEX,,73.0,YR,,F,Y,,,20190506.0,,CN,CA,CA,2019,Q2,Elderly
162437972,16243797,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, Q.WK.",,,U,U,,,,7.5,MG,,/wk,2019,Q2,Frequent bowel movements,,2019,Q2,2,F,,20190424.0,20190426,20190506,EXP,,CA-APOTEX-2019AP012426,APOTEX,,73.0,YR,,F,Y,,,20190506.0,,CN,CA,CA,2019,Q2,Elderly
162437972,16243797,10,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, Q.WK.",,,U,U,,,,7.5,MG,,/wk,2019,Q2,Rectal haemorrhage,,2019,Q2,2,F,,20190424.0,20190426,20190506,EXP,,CA-APOTEX-2019AP012426,APOTEX,,73.0,YR,,F,Y,,,20190506.0,,CN,CA,CA,2019,Q2,Elderly
162662071,16266207,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,0.14285713,DF,U,, UNKNOWN,,,1.0,DF,,,2019,Q2,Chest discomfort,,2019,Q2,1,I,20190211.0,20190425.0,20190502,20190502,EXP,GB-MHRA-TPP26847974C964450YC1553763944953,GB-TEVA-2019-GB-1044276,TEVA,,61.0,YR,,M,Y,103.0,KG,20190502.0,,MD,GB,GB,2019,Q2,Adult
162702321,16270232,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:.75MG;?,,,,,,,,0.75,MG,,QW,2019,Q2,Abdominal pain,,2019,Q2,1,I,20190109.0,,20190329,20190329,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20190318.0,N,PH,US,US,2019,Q2,Adult
162702321,16270232,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:.75MG;?,,,,,,,,0.75,MG,,QW,2019,Q2,Drug intolerance,,2019,Q2,1,I,20190109.0,,20190329,20190329,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20190318.0,N,PH,US,US,2019,Q2,Adult
162767602,16276760,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,2,F,,20190422.0,20190506,20190507,EXP,,US-ZYDUS-036167,NESHER,,60.0,YR,,F,Y,,,20190507.0,,CN,US,US,2019,Q2,Adult
162767602,16276760,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,U,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,2,F,,20190422.0,20190506,20190507,EXP,,US-ZYDUS-036167,NESHER,,60.0,YR,,F,Y,,,20190507.0,,CN,US,US,2019,Q2,Adult
163059321,16305932,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM,,,U,U, UNK,,,1.5,MG,,,2019,Q2,Off label use,,2019,Q2,1,I,20180728.0,20190506.0,20190513,20190513,EXP,,GB-MYLANLABS-2019M1044241,MYLAN,,43.0,YR,,F,Y,,,20190513.0,,MD,GB,GB,2019,Q2,Adult
163059321,16305932,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM,,,U,U, UNK,,,1.5,MG,,,2019,Q2,Seizure,,2019,Q2,1,I,20180728.0,20190506.0,20190513,20190513,EXP,,GB-MYLANLABS-2019M1044241,MYLAN,,43.0,YR,,F,Y,,,20190513.0,,MD,GB,GB,2019,Q2,Adult
163121161,16312116,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,ON A THURSDAY,33.205,MG,Y,,,,,1.5,MG,,/wk,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190405.0,20190508.0,20190515,20190515,EXP,GB-MHRA-EYC 00198699,GB-SA-2019SA127139,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190515.0,,PH,GB,GB,2019,Q2,Adult
163121161,16312116,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,ON A THURSDAY,33.205,MG,Y,,,,,1.5,MG,,/wk,2019,Q2,Nausea,,2019,Q2,1,I,20190405.0,20190508.0,20190515,20190515,EXP,GB-MHRA-EYC 00198699,GB-SA-2019SA127139,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190515.0,,PH,GB,GB,2019,Q2,Adult
163121161,16312116,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Oral,ON A THURSDAY,33.205,MG,Y,,,,,1.5,MG,,/wk,2019,Q2,Vomiting,,2019,Q2,1,I,20190405.0,20190508.0,20190515,20190515,EXP,GB-MHRA-EYC 00198699,GB-SA-2019SA127139,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20190515.0,,PH,GB,GB,2019,Q2,Adult
163251231,16325123,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Device malfunction,,2019,Q2,1,I,20190511.0,,20190516,20190516,DIR,,,FDA-CTU,,57.0,YR,,M,N,112.5,KG,20190516.0,N,CN,US,US,2019,Q2,Adult
163251231,16325123,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Incorrect dose administered,,2019,Q2,1,I,20190511.0,,20190516,20190516,DIR,,,FDA-CTU,,57.0,YR,,M,N,112.5,KG,20190516.0,N,CN,US,US,2019,Q2,Adult
163268791,16326879,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,, UNK,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,20170101.0,20190510.0,20190517,20190517,EXP,FR-AFSSAPS-AM20181340,FR-MYLANLABS-2019M1046145,MYLAN,,69.0,YR,,F,Y,85.0,KG,20190517.0,,MD,FR,FR,2019,Q2,Elderly
163268791,16326879,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,, UNK,,,,,,,2019,Q2,Hypotension,,2019,Q2,1,I,20170101.0,20190510.0,20190517,20190517,EXP,FR-AFSSAPS-AM20181340,FR-MYLANLABS-2019M1046145,MYLAN,,69.0,YR,,F,Y,85.0,KG,20190517.0,,MD,FR,FR,2019,Q2,Elderly
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Abdominal abscess,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Cerebrovascular accident,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Cyst,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Desmoid tumour,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Hernia,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Hernia perforation,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163335991,16333599,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Incarcerated hernia,,2019,Q2,1,I,2016.0,20190422.0,20190520,20190520,EXP,,US-ABBVIE-19K-163-2755346-00,ABBVIE,,64.0,YR,,F,Y,120.31,KG,20190520.0,,CN,US,US,2019,Q2,Adult
163472321,16347232,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Diabetic ketoacidosis,,2019,Q2,1,I,20190415.0,20190517.0,20190523,20190523,EXP,,GB-ASTRAZENECA-2019SE75295,ASTRAZENECA,,57.0,YR,,F,Y,80.0,KG,20190523.0,,,GB,GB,2019,Q2,Adult
163644362,16364436,21,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,2,F,20150728.0,20190619.0,20190528,20190624,EXP,,US-TAKEDA-2019TUS008385,TAKEDA,,74.0,YR,,M,Y,,,20190624.0,,LW,US,US,2019,Q2,Elderly
164146512,16414651,19,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Cardiac failure acute,,2019,Q2,2,F,20190606.0,20190626.0,20190611,20190627,EXP,,US-GILEAD-2019-0409771,GILEAD,,60.0,YR,A,M,Y,102.9,KG,20190627.0,,OT,US,US,2019,Q2,Adult
164146512,16414651,19,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q2,Renal disorder,,2019,Q2,2,F,20190606.0,20190626.0,20190611,20190627,EXP,,US-GILEAD-2019-0409771,GILEAD,,60.0,YR,A,M,Y,102.9,KG,20190627.0,,OT,US,US,2019,Q2,Adult
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Abdominal pain,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Diarrhoea,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Dizziness,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Fatigue,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Nausea,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164246811,16424681,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,125469.0,,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2019,Q2,Vomiting,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201906002900,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20190613.0,,MD,RO,RO,2019,Q2,Elderly
164280881,16428088,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,0.75MG/0.5ML,,,U,U,,,125469.0,,,,,2019,Q2,Dizziness,,2019,Q2,1,I,20170221.0,20190603.0,20190613,20190613,EXP,GB-MHRA-INPF8A8C7F3-A401-4499-8632-329B92FCD14F,GB-ELI_LILLY_AND_COMPANY-GB201906001218,ELI LILLY AND CO,,66.0,YR,,F,Y,140.2,KG,20190613.0,,CN,GB,GB,2019,Q2,Elderly
164280881,16428088,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,0.75MG/0.5ML,,,U,U,,,125469.0,,,,,2019,Q2,Nausea,,2019,Q2,1,I,20170221.0,20190603.0,20190613,20190613,EXP,GB-MHRA-INPF8A8C7F3-A401-4499-8632-329B92FCD14F,GB-ELI_LILLY_AND_COMPANY-GB201906001218,ELI LILLY AND CO,,66.0,YR,,F,Y,140.2,KG,20190613.0,,CN,GB,GB,2019,Q2,Elderly
164388301,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q2,Decreased appetite,,2019,Q2,1,I,20190214.0,20190517.0,20190617,20190617,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190617.0,,MD,JP,JP,2019,Q2,Child
164388301,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q2,Dehydration,,2019,Q2,1,I,20190214.0,20190517.0,20190617,20190617,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190617.0,,MD,JP,JP,2019,Q2,Child
164388301,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,1,I,20190214.0,20190517.0,20190617,20190617,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190617.0,,MD,JP,JP,2019,Q2,Child
164712611,16471261,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,,,,125469.0,1.5,MG,,,2019,Q2,Abnormal loss of weight,,2019,Q2,1,I,,20190619.0,20190624,20190624,EXP,GB-MHRA-EYC 00201093,GB-ELI_LILLY_AND_COMPANY-GB201906009466,ELI LILLY AND CO,,64.0,YR,,M,Y,124.0,KG,20190624.0,,CN,GB,GB,2019,Q2,Adult
164712611,16471261,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,,,,125469.0,1.5,MG,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,,20190619.0,20190624,20190624,EXP,GB-MHRA-EYC 00201093,GB-ELI_LILLY_AND_COMPANY-GB201906009466,ELI LILLY AND CO,,64.0,YR,,M,Y,124.0,KG,20190624.0,,CN,GB,GB,2019,Q2,Adult
164712611,16471261,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,,,,125469.0,1.5,MG,,,2019,Q2,Decreased appetite,,2019,Q2,1,I,,20190619.0,20190624,20190624,EXP,GB-MHRA-EYC 00201093,GB-ELI_LILLY_AND_COMPANY-GB201906009466,ELI LILLY AND CO,,64.0,YR,,M,Y,124.0,KG,20190624.0,,CN,GB,GB,2019,Q2,Adult
164712611,16471261,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,,,,125469.0,1.5,MG,,,2019,Q2,Eosinophilia,,2019,Q2,1,I,,20190619.0,20190624,20190624,EXP,GB-MHRA-EYC 00201093,GB-ELI_LILLY_AND_COMPANY-GB201906009466,ELI LILLY AND CO,,64.0,YR,,M,Y,124.0,KG,20190624.0,,CN,GB,GB,2019,Q2,Adult
164712611,16471261,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,Y,,,,125469.0,1.5,MG,,,2019,Q2,Pyrexia,,2019,Q2,1,I,,20190619.0,20190624,20190624,EXP,GB-MHRA-EYC 00201093,GB-ELI_LILLY_AND_COMPANY-GB201906009466,ELI LILLY AND CO,,64.0,YR,,M,Y,124.0,KG,20190624.0,,CN,GB,GB,2019,Q2,Adult
164749261,16474926,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,,6.643,MG,Y,,,,125469.0,1.5,MG,,/wk,2019,Q2,Incorrect route of product administration,,2019,Q2,1,I,20190104.0,20190620.0,20190625,20190625,EXP,GB-MHRA-EYC 00201539,GB-ELI_LILLY_AND_COMPANY-GB201906010195,ELI LILLY AND CO,,44.0,YR,,F,Y,130.0,KG,20190625.0,,CN,GB,GB,2019,Q2,Adult
164749261,16474926,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intramuscular,,6.643,MG,Y,,,,125469.0,1.5,MG,,/wk,2019,Q2,Psoriasis,,2019,Q2,1,I,20190104.0,20190620.0,20190625,20190625,EXP,GB-MHRA-EYC 00201539,GB-ELI_LILLY_AND_COMPANY-GB201906010195,ELI LILLY AND CO,,44.0,YR,,F,Y,130.0,KG,20190625.0,,CN,GB,GB,2019,Q2,Adult
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Back pain,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Blood pressure fluctuation,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Cataract,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Condition aggravated,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Heart rate irregular,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Pain in extremity,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Product use issue,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Therapeutic product effect incomplete,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Back pain,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Blood pressure fluctuation,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Cataract,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Condition aggravated,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Heart rate irregular,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Pain in extremity,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Product use issue,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
164922182,16492218,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q2,Therapeutic product effect incomplete,,2019,Q2,2,F,,20190613.0,20190628,20190628,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-15819,SAMSUNG BIOEPIS,,73.0,YR,,F,Y,86.0,KG,20190625.0,,MD,CA,CA,2019,Q2,Elderly
132871032,13287103,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, WEEKLY (1/W)",,,U,U,,,125469.0,,,INJECTION,/wk,2019,Q3,Diabetic complication,,2019,Q3,2,F,,20190624.0,20170302,20190702,EXP,,US-ELI_LILLY_AND_COMPANY-US201702010280,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190702.0,,MD,US,US,2019,Q3,Adult
132871032,13287103,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, WEEKLY (1/W)",,,U,U,,,125469.0,,,INJECTION,/wk,2019,Q3,Fournier's gangrene,,2019,Q3,2,F,,20190624.0,20170302,20190702,EXP,,US-ELI_LILLY_AND_COMPANY-US201702010280,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190702.0,,MD,US,US,2019,Q3,Adult
155235102,15523510,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,2,F,20170101.0,20190902.0,20181018,20190917,EXP,FR-AFSSAPS-AM20181340,FR-ZYDUS-029146,ZYDUS PHARM,,69.0,YR,,F,Y,85.0,KG,20190917.0,,MD,FR,FR,2019,Q3,Elderly
155235102,15523510,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,20170101.0,20190902.0,20181018,20190917,EXP,FR-AFSSAPS-AM20181340,FR-ZYDUS-029146,ZYDUS PHARM,,69.0,YR,,F,Y,85.0,KG,20190917.0,,MD,FR,FR,2019,Q3,Elderly
155314273,15531427,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intracardiac,UNK,,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,3,F,20170101.0,20190830.0,20181019,20190912,EXP,,FR-AUROBINDO-AUR-APL-2018-050877,AUROBINDO,,69.0,YR,,F,Y,85.0,KG,20190913.0,,CN,FR,FR,2019,Q3,Elderly
155314273,15531427,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Intracardiac,UNK,,,U,U,,,,,,,,2019,Q3,Hypotension,,2019,Q3,3,F,20170101.0,20190830.0,20181019,20190912,EXP,,FR-AUROBINDO-AUR-APL-2018-050877,AUROBINDO,,69.0,YR,,F,Y,85.0,KG,20190913.0,,CN,FR,FR,2019,Q3,Elderly
155506392,15550639,9,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,Unknown,(),,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,2,F,20170101.0,20190905.0,20181025,20190919,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-189091,RANBAXY,,69.0,YR,,F,Y,85.0,KG,20190919.0,,OT,NL,FR,2019,Q3,Elderly
155506392,15550639,9,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,Unknown,(),,,U,U,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,20170101.0,20190905.0,20181025,20190919,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-189091,RANBAXY,,69.0,YR,,F,Y,85.0,KG,20190919.0,,OT,NL,FR,2019,Q3,Elderly
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Ageusia,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Asthenia,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Dehydration,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Dizziness,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Dry mouth,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Eructation,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Heart rate increased,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Nausea,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Off label use,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
157349652,15734965,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Parenteral,"1.5 MG, WEEKLY (1/W)",0.214,MG,Y,, N/A,,125469.0,1.5,MG,,/wk,2019,Q3,Vomiting,,2019,Q3,2,F,20180808.0,20190822.0,20181218,20190828,EXP,GB-MHRA-EYC 00190862,GB-ELI_LILLY_AND_COMPANY-GB201812006101,ELI LILLY AND CO,,60.0,YR,,F,Y,62.0,KG,20190828.0,,CN,GB,GB,2019,Q3,Adult
159953723,15995372,22,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,3,F,20150728.0,20190829.0,20190222,20190902,EXP,,US-PFIZER INC-2019082144,PFIZER,,74.0,YR,,M,Y,,,20190902.0,,LW,US,US,2019,Q3,Elderly
160125473,16012547,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q3,Portal vein thrombosis,,2019,Q3,3,F,20181124.0,20190619.0,20190227,20190826,PER,,US-DOVA PHARMACEUTICALS INC.-DOV-000242,DOVA PHARMACEUTICALS,,63.0,YR,,F,Y,105.21,KG,20190826.0,,CN,US,US,2019,Q3,Adult
160794412,16079441,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Fluid overload,,2019,Q3,2,F,20190120.0,20190709.0,20190315,20190718,EXP,,US-SHIRE-US201907966,SHIRE,,58.0,YR,,M,Y,115.3,KG,20190718.0,,OT,US,US,2019,Q3,Adult
160794412,16079441,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Hypokalaemia,,2019,Q3,2,F,20190120.0,20190709.0,20190315,20190718,EXP,,US-SHIRE-US201907966,SHIRE,,58.0,YR,,M,Y,115.3,KG,20190718.0,,OT,US,US,2019,Q3,Adult
160794412,16079441,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Myocardial infarction,,2019,Q3,2,F,20190120.0,20190709.0,20190315,20190718,EXP,,US-SHIRE-US201907966,SHIRE,,58.0,YR,,M,Y,115.3,KG,20190718.0,,OT,US,US,2019,Q3,Adult
160794412,16079441,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Oedema peripheral,,2019,Q3,2,F,20190120.0,20190709.0,20190315,20190718,EXP,,US-SHIRE-US201907966,SHIRE,,58.0,YR,,M,Y,115.3,KG,20190718.0,,OT,US,US,2019,Q3,Adult
164388302,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q3,Decreased appetite,,2019,Q3,2,F,20190214.0,20190610.0,20190617,20190718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190718.0,,MD,JP,JP,2019,Q3,Child
164388302,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q3,Dehydration,,2019,Q3,2,F,20190214.0,20190610.0,20190617,20190718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190718.0,,MD,JP,JP,2019,Q3,Child
164388302,16438830,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,INJECTION,,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,2,F,20190214.0,20190610.0,20190617,20190718,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002147",BOEHRINGER INGELHEIM,,10.0,DEC,,F,Y,,,20190718.0,,MD,JP,JP,2019,Q3,Child
164749242,16474924,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Pruritus,,2019,Q3,2,F,20190529.0,20190624.0,20190625,20190702,EXP,GB-MHRA-TPP31778357C2665039YC1559137730801,GB-ELI_LILLY_AND_COMPANY-GB201906010286,ELI LILLY AND CO,,70.0,YR,,F,Y,93.0,KG,20190702.0,,CN,GB,GB,2019,Q3,Elderly
164749242,16474924,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Rash papular,,2019,Q3,2,F,20190529.0,20190624.0,20190625,20190702,EXP,GB-MHRA-TPP31778357C2665039YC1559137730801,GB-ELI_LILLY_AND_COMPANY-GB201906010286,ELI LILLY AND CO,,70.0,YR,,F,Y,93.0,KG,20190702.0,,CN,GB,GB,2019,Q3,Elderly
165490471,16549047,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Hiccups,,2019,Q3,1,I,20180129.0,20190628.0,20190709,20190709,EXP,ES-AEMPS-512784,ES-ELI_LILLY_AND_COMPANY-ES201907000598,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20190709.0,,CN,ES,ES,2019,Q3,Adult
165570593,16557059,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QWK",,,,,,,,0.5,MG,,/wk,2019,Q3,Blood glucose decreased,,2019,Q3,3,F,20190701.0,20190715.0,20190711,20190722,PER,,US-AMGEN-USASP2019107622,AMGEN,,70.0,YR,E,F,Y,92.97,KG,20190721.0,,CN,US,US,2019,Q3,Elderly
165570593,16557059,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QWK",,,,,,,,0.5,MG,,/wk,2019,Q3,Dizziness,,2019,Q3,3,F,20190701.0,20190715.0,20190711,20190722,PER,,US-AMGEN-USASP2019107622,AMGEN,,70.0,YR,E,F,Y,92.97,KG,20190721.0,,CN,US,US,2019,Q3,Elderly
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Altered state of consciousness,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Brain oedema,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Coma scale abnormal,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Dehydration,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Ketoacidosis,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165571873,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Post procedural complication,,2019,Q3,3,F,20190704.0,20190904.0,20190711,20190906,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20190906.0,,MD,DE,DE,2019,Q3,Adult
165797951,16579795,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,INJECTION,,2019,Q3,Syncope,,2019,Q3,1,I,20190106.0,20190617.0,20190716,20190716,EXP,,US-MYLANLABS-2019M1058239,MYLAN,,67.0,YR,,M,Y,114.3,KG,20190716.0,,MD,US,US,2019,Q3,Elderly
165810021,16581002,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,U,,,125469.0,0.75,MG,,/wk,2019,Q3,Pancreatitis,,2019,Q3,1,I,20190624.0,20190710.0,20190716,20190716,EXP,ES-AEMPS-517318,ES-ELI_LILLY_AND_COMPANY-ES201907006375,ELI LILLY AND CO,,80.0,YR,,M,Y,70.0,KG,20190716.0,,CN,ES,ES,2019,Q3,Elderly
165882223,16588222,1,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, WEEKLY (1/W)",28.5,MG,,,,,,0.75,MG,SOLUTION FOR INJECTION,/wk,2019,Q3,Death,,2019,Q3,3,F,20171021.0,20190829.0,20190717,20190904,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201907006711,ELI LILLY AND CO,,68.0,YR,,F,Y,88.0,KG,20190904.0,,CN,JP,JP,2019,Q3,Elderly
166258151,16625815,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",84.0,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Lithiasis,,2019,Q3,1,I,20190316.0,20190715.0,20190724,20190724,EXP,IT-MINISAL02-562909,IT-ELI_LILLY_AND_COMPANY-IT201907008515,ELI LILLY AND CO,,68.0,YR,,F,Y,78.0,KG,20190724.0,,CN,IT,IT,2019,Q3,Elderly
166258151,16625815,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",84.0,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Pancreatitis acute,,2019,Q3,1,I,20190316.0,20190715.0,20190724,20190724,EXP,IT-MINISAL02-562909,IT-ELI_LILLY_AND_COMPANY-IT201907008515,ELI LILLY AND CO,,68.0,YR,,F,Y,78.0,KG,20190724.0,,CN,IT,IT,2019,Q3,Elderly
166312021,16631202,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,U,U,,,,1.5,MG,,/wk,2019,Q3,Accidental overdose,,2019,Q3,1,I,20190503.0,20190722.0,20190725,20190725,EXP,,PHHY2019IT170523,SANDOZ,,47.0,YR,,F,Y,,,20190725.0,,OT,IT,IT,2019,Q3,Adult
166312021,16631202,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,U,U,,,,1.5,MG,,/wk,2019,Q3,Drug interaction,,2019,Q3,1,I,20190503.0,20190722.0,20190725,20190725,EXP,,PHHY2019IT170523,SANDOZ,,47.0,YR,,F,Y,,,20190725.0,,OT,IT,IT,2019,Q3,Adult
166312021,16631202,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,U,U,,,,1.5,MG,,/wk,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190503.0,20190722.0,20190725,20190725,EXP,,PHHY2019IT170523,SANDOZ,,47.0,YR,,F,Y,,,20190725.0,,OT,IT,IT,2019,Q3,Adult
166496612,16649661,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.2,MG,,QD,2019,Q3,Transient ischaemic attack,,2019,Q3,2,F,20190620.0,20190819.0,20190730,20190820,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-031033",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,77.0,KG,20190820.0,,MD,US,US,2019,Q3,Elderly
166496612,16649661,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,0.2,MG,,QD,2019,Q3,Vertigo,,2019,Q3,2,F,20190620.0,20190819.0,20190730,20190820,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-031033",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,77.0,KG,20190820.0,,MD,US,US,2019,Q3,Elderly
166568271,16656827,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q3,Iron deficiency anaemia,,2019,Q3,1,I,20180901.0,20190730.0,20190801,20190801,EXP,IT-MINISAL02-565161,IT-JNJFOC-20190743448,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,88.0,KG,20190801.0,,MD,IT,IT,2019,Q3,Elderly
166577771,16657777,11,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20170101.0,20190719.0,20190801,20190801,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-075242,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,85.0,KG,20190801.0,,OT,FR,FR,2019,Q3,Elderly
166577771,16657777,11,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,20170101.0,20190719.0,20190801,20190801,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-075242,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,85.0,KG,20190801.0,,OT,FR,FR,2019,Q3,Elderly
166621571,16662157,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QD,2019,Q3,Euglycaemic diabetic ketoacidosis,,2019,Q3,1,I,20190613.0,,20190802,20190802,DIR,,,FDA-CTU,,23.0,YR,,F,N,118.0,KG,20190802.0,N,,US,US,2019,Q3,Youth
166640971,16664097,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20170101.0,20190726.0,20190802,20190802,EXP,,FR-BAUSCH-BL-2019-021721,BAUSCH AND LOMB,,69.0,YR,,F,Y,85.0,KG,20190802.0,,CN,FR,FR,2019,Q3,Elderly
166640971,16664097,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,20170101.0,20190726.0,20190802,20190802,EXP,,FR-BAUSCH-BL-2019-021721,BAUSCH AND LOMB,,69.0,YR,,F,Y,85.0,KG,20190802.0,,CN,FR,FR,2019,Q3,Elderly
166795821,16679582,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,USE AS DIRECTED.,,,,," UNKNOWN,UNKNOWN",,,,,,,2019,Q3,Liver function test abnormal,,2019,Q3,1,I,20190626.0,20190805.0,20190807,20190807,EXP,GB-MHRA-TPP29997837C970355YC1561534315143,GB-TEVA-2019-GB-1089415,TEVA,,57.0,YR,,F,Y,78.0,KG,20190807.0,,MD,GB,GB,2019,Q3,Adult
166858271,16685827,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, 1 IN 1 WK",,,U,, UNKNOWN,,,1.5,MG,,,2019,Q3,Accidental overdose,,2019,Q3,1,I,20190503.0,20190718.0,20190809,20190809,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-074040,BRISTOL MYERS SQUIBB,,47.0,YR,,F,Y,,,20190809.0,,MD,IT,IT,2019,Q3,Adult
166858271,16685827,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, 1 IN 1 WK",,,U,, UNKNOWN,,,1.5,MG,,,2019,Q3,Drug interaction,,2019,Q3,1,I,20190503.0,20190718.0,20190809,20190809,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-074040,BRISTOL MYERS SQUIBB,,47.0,YR,,F,Y,,,20190809.0,,MD,IT,IT,2019,Q3,Adult
166858271,16685827,3,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, 1 IN 1 WK",,,U,, UNKNOWN,,,1.5,MG,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190503.0,20190718.0,20190809,20190809,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-074040,BRISTOL MYERS SQUIBB,,47.0,YR,,F,Y,,,20190809.0,,MD,IT,IT,2019,Q3,Adult
166898702,16689870,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, DAILY",39.0,MG,Y,U,,,125469.0,0.75,MG,,QD,2019,Q3,Acute coronary syndrome,,2019,Q3,2,F,20190513.0,20190830.0,20190809,20190911,EXP,IT-MINISAL02-565865,IT-ELI_LILLY_AND_COMPANY-IT201907016161,ELI LILLY AND CO,,52.0,YR,,F,Y,131.0,KG,20190911.0,,CN,IT,IT,2019,Q3,Adult
166898702,16689870,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, DAILY",39.0,MG,Y,U,,,125469.0,0.75,MG,,QD,2019,Q3,Inappropriate schedule of product administration,,2019,Q3,2,F,20190513.0,20190830.0,20190809,20190911,EXP,IT-MINISAL02-565865,IT-ELI_LILLY_AND_COMPANY-IT201907016161,ELI LILLY AND CO,,52.0,YR,,F,Y,131.0,KG,20190911.0,,CN,IT,IT,2019,Q3,Adult
166898702,16689870,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, DAILY",39.0,MG,Y,U,,,125469.0,0.75,MG,,QD,2019,Q3,Overdose,,2019,Q3,2,F,20190513.0,20190830.0,20190809,20190911,EXP,IT-MINISAL02-565865,IT-ELI_LILLY_AND_COMPANY-IT201907016161,ELI LILLY AND CO,,52.0,YR,,F,Y,131.0,KG,20190911.0,,CN,IT,IT,2019,Q3,Adult
166898702,16689870,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, DAILY",39.0,MG,Y,U,,,125469.0,0.75,MG,,QD,2019,Q3,Sinus tachycardia,,2019,Q3,2,F,20190513.0,20190830.0,20190809,20190911,EXP,IT-MINISAL02-565865,IT-ELI_LILLY_AND_COMPANY-IT201907016161,ELI LILLY AND CO,,52.0,YR,,F,Y,131.0,KG,20190911.0,,CN,IT,IT,2019,Q3,Adult
166898702,16689870,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, DAILY",39.0,MG,Y,U,,,125469.0,0.75,MG,,QD,2019,Q3,Throat tightness,,2019,Q3,2,F,20190513.0,20190830.0,20190809,20190911,EXP,IT-MINISAL02-565865,IT-ELI_LILLY_AND_COMPANY-IT201907016161,ELI LILLY AND CO,,52.0,YR,,F,Y,131.0,KG,20190911.0,,CN,IT,IT,2019,Q3,Adult
167015411,16701541,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",58.929,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190603.0,20190802.0,20190814,20190814,EXP,GB-MHRA-EYC 00201934,GB-ELI_LILLY_AND_COMPANY-GB201908001977,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190814.0,,CN,GB,GB,2019,Q3,Adult
167015411,16701541,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",58.929,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190603.0,20190802.0,20190814,20190814,EXP,GB-MHRA-EYC 00201934,GB-ELI_LILLY_AND_COMPANY-GB201908001977,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190814.0,,CN,GB,GB,2019,Q3,Adult
167015411,16701541,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",58.929,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Lethargy,,2019,Q3,1,I,20190603.0,20190802.0,20190814,20190814,EXP,GB-MHRA-EYC 00201934,GB-ELI_LILLY_AND_COMPANY-GB201908001977,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190814.0,,CN,GB,GB,2019,Q3,Adult
167015411,16701541,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",58.929,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Syncope,,2019,Q3,1,I,20190603.0,20190802.0,20190814,20190814,EXP,GB-MHRA-EYC 00201934,GB-ELI_LILLY_AND_COMPANY-GB201908001977,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190814.0,,CN,GB,GB,2019,Q3,Adult
167015411,16701541,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",58.929,MG,Y,U,,,125469.0,1.5,MG,,/wk,2019,Q3,Tremor,,2019,Q3,1,I,20190603.0,20190802.0,20190814,20190814,EXP,GB-MHRA-EYC 00201934,GB-ELI_LILLY_AND_COMPANY-GB201908001977,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190814.0,,CN,GB,GB,2019,Q3,Adult
167104481,16710448,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Headache,,2019,Q3,1,I,,20190809.0,20190816,20190816,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201908004850,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20190816.0,,CN,IN,IN,2019,Q3,Elderly
167104481,16710448,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Rhinorrhoea,,2019,Q3,1,I,,20190809.0,20190816,20190816,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201908004850,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20190816.0,,CN,IN,IN,2019,Q3,Elderly
167237341,16723734,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,U,,,,,,,,,2019,Q3,Non-Hodgkin's lymphoma,,2019,Q3,1,I,,20190820.0,20190821,20190821,EXP,GB-MHRA-EYC 00205541,GB-SA-2019SA231187,SANOFI AVENTIS,,51.0,YR,A,F,Y,,,20190821.0,,OT,GB,GB,2019,Q3,Adult
167238231,16723823,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190603.0,20190815.0,20190821,20190821,EXP,GB-MHRA-EYC 00201937,GB-ELI_LILLY_AND_COMPANY-GB201908007414,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190821.0,,CN,GB,GB,2019,Q3,Adult
167238231,16723823,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190603.0,20190815.0,20190821,20190821,EXP,GB-MHRA-EYC 00201937,GB-ELI_LILLY_AND_COMPANY-GB201908007414,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190821.0,,CN,GB,GB,2019,Q3,Adult
167238231,16723823,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Lethargy,,2019,Q3,1,I,20190603.0,20190815.0,20190821,20190821,EXP,GB-MHRA-EYC 00201937,GB-ELI_LILLY_AND_COMPANY-GB201908007414,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190821.0,,CN,GB,GB,2019,Q3,Adult
167238231,16723823,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Syncope,,2019,Q3,1,I,20190603.0,20190815.0,20190821,20190821,EXP,GB-MHRA-EYC 00201937,GB-ELI_LILLY_AND_COMPANY-GB201908007414,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190821.0,,CN,GB,GB,2019,Q3,Adult
167238231,16723823,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q3,Tremor,,2019,Q3,1,I,20190603.0,20190815.0,20190821,20190821,EXP,GB-MHRA-EYC 00201937,GB-ELI_LILLY_AND_COMPANY-GB201908007414,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20190821.0,,CN,GB,GB,2019,Q3,Adult
167251961,16725196,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Pancreatitis,,2019,Q3,1,I,20181202.0,,20190704,20190704,DIR,,,FDA-CTU,,35.0,YR,,M,N,,,20190128.0,N,PH,US,US,2019,Q3,Adult
167477481,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2019,Q3,Arthritis,,2019,Q3,1,I,201902.0,20190507.0,20190827,20190827,EXP,,PHHY2019CZ110078,SANDOZ,,71.0,YR,,M,Y,,,20190827.0,,OT,CZ,CZ,2019,Q3,Elderly
167477481,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,1,I,201902.0,20190507.0,20190827,20190827,EXP,,PHHY2019CZ110078,SANDOZ,,71.0,YR,,M,Y,,,20190827.0,,OT,CZ,CZ,2019,Q3,Elderly
167477481,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2019,Q3,Drug ineffective,,2019,Q3,1,I,201902.0,20190507.0,20190827,20190827,EXP,,PHHY2019CZ110078,SANDOZ,,71.0,YR,,M,Y,,,20190827.0,,OT,CZ,CZ,2019,Q3,Elderly
167477481,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2019,Q3,Hypokinesia,,2019,Q3,1,I,201902.0,20190507.0,20190827,20190827,EXP,,PHHY2019CZ110078,SANDOZ,,71.0,YR,,M,Y,,,20190827.0,,OT,CZ,CZ,2019,Q3,Elderly
167477481,16747748,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,/wk,2019,Q3,Spinal pain,,2019,Q3,1,I,201902.0,20190507.0,20190827,20190827,EXP,,PHHY2019CZ110078,SANDOZ,,71.0,YR,,M,Y,,,20190827.0,,OT,CZ,CZ,2019,Q3,Elderly
167692591,16769259,1,PS,Dulaglutide 1.5mg,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190823.0,20190903,20190903,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201908012407,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190903.0,,CN,IN,IN,2019,Q3,Adult
167777811,16777781,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,N,U,,,125469.0,1.5,MG,,,2019,Q3,Atrioventricular block complete,,2019,Q3,1,I,20190812.0,20190827.0,20190905,20190905,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20190905.0,,CN,GB,GB,2019,Q3,Elderly
167777811,16777781,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, UNKNOWN",,,N,U,,,125469.0,1.5,MG,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,20190812.0,20190827.0,20190905,20190905,EXP,GB-MHRA-EYC 00206271,GB-ELI_LILLY_AND_COMPANY-GB201908013655,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20190905.0,,CN,GB,GB,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Abdominal pain,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Dizziness,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Headache,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Injection site pain,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Nausea,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Overdose,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Tremor,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Abdominal pain,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Dizziness,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Headache,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Injection site pain,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Nausea,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Overdose,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167818571,16781857,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"6 MG, SINGLE",,,U,U,,,125469.0,6.0,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q3,Tremor,,2019,Q3,1,I,,20190901.0,20190906,20190906,EXP,,US-ELI_LILLY_AND_COMPANY-US201909000374,ELI LILLY AND CO,RINNER G..GRAND GLP-1 GLIMPSE..CLINICAL TOXICOLOGY. CONFERENCE: NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY. 2019;57(10):1032-1033.,81.0,YR,,M,Y,,,20190906.0,,OT,US,US,2019,Q3,Elderly
167867151,16786715,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20170101.0,20190902.0,20190909,20190909,EXP,FR-EMA-DD-20190828-PAWAR_P-085615,PHHY2019FR205435,SANDOZ,,69.0,YR,,F,Y,85.0,KG,20190909.0,,OT,FR,FR,2019,Q3,Elderly
167867151,16786715,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,20170101.0,20190902.0,20190909,20190909,EXP,FR-EMA-DD-20190828-PAWAR_P-085615,PHHY2019FR205435,SANDOZ,,69.0,YR,,F,Y,85.0,KG,20190909.0,,OT,FR,FR,2019,Q3,Elderly
167934771,16793477,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20170101.0,20181005.0,20190911,20190911,EXP,FR-AFSSAPS-AM20181340,FR-EMD SERONO-E2B_90061640,EMD SERONO INC,,69.0,YR,,F,Y,85.0,KG,20190911.0,,CN,FR,FR,2019,Q3,Elderly
167934771,16793477,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,20170101.0,20181005.0,20190911,20190911,EXP,FR-AFSSAPS-AM20181340,FR-EMD SERONO-E2B_90061640,EMD SERONO INC,,69.0,YR,,F,Y,85.0,KG,20190911.0,,CN,FR,FR,2019,Q3,Elderly
168010731,16801073,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Abdominal pain,,2019,Q3,1,I,20190724.0,20190905.0,20190912,20190912,EXP,,PHHY2019GB206998,NOVARTIS,,50.0,YR,,M,Y,,,20190912.0,,OT,GB,GB,2019,Q3,Adult
168010731,16801073,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Colitis ulcerative,,2019,Q3,1,I,20190724.0,20190905.0,20190912,20190912,EXP,,PHHY2019GB206998,NOVARTIS,,50.0,YR,,M,Y,,,20190912.0,,OT,GB,GB,2019,Q3,Adult
168010731,16801073,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,1,I,20190724.0,20190905.0,20190912,20190912,EXP,,PHHY2019GB206998,NOVARTIS,,50.0,YR,,M,Y,,,20190912.0,,OT,GB,GB,2019,Q3,Adult
168010731,16801073,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Diarrhoea haemorrhagic,,2019,Q3,1,I,20190724.0,20190905.0,20190912,20190912,EXP,,PHHY2019GB206998,NOVARTIS,,50.0,YR,,M,Y,,,20190912.0,,OT,GB,GB,2019,Q3,Adult
168061111,16806111,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20190809.0,20190911.0,20190913,20190913,EXP,FR-AFSSAPS-BX20191556,FR-BAUSCH-BL-2019-026218,BAUSCH AND LOMB,,73.0,YR,,F,Y,97.0,KG,20190913.0,,MD,FR,FR,2019,Q3,Elderly
168061111,16806111,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Metabolic acidosis,,2019,Q3,1,I,20190809.0,20190911.0,20190913,20190913,EXP,FR-AFSSAPS-BX20191556,FR-BAUSCH-BL-2019-026218,BAUSCH AND LOMB,,73.0,YR,,F,Y,97.0,KG,20190913.0,,MD,FR,FR,2019,Q3,Elderly
168077961,16807796,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20190809.0,20190911.0,20190915,20190915,EXP,,PHHY2019FR212440,SANDOZ,,73.0,YR,,F,Y,97.0,KG,20190915.0,,OT,FR,FR,2019,Q3,Elderly
168077961,16807796,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2019,Q3,Metabolic acidosis,,2019,Q3,1,I,20190809.0,20190911.0,20190915,20190915,EXP,,PHHY2019FR212440,SANDOZ,,73.0,YR,,F,Y,97.0,KG,20190915.0,,OT,FR,FR,2019,Q3,Elderly
168255111,16825511,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20190809.0,20190912.0,20190919,20190919,EXP,FR-AFSSAPS-BX20191556,FR-EMD SERONO-E2B_90070791,EMD SERONO INC,,73.0,YR,,F,Y,97.0,KG,20190919.0,,MD,FR,FR,2019,Q3,Elderly
168255111,16825511,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Metabolic acidosis,,2019,Q3,1,I,20190809.0,20190912.0,20190919,20190919,EXP,FR-AFSSAPS-BX20191556,FR-EMD SERONO-E2B_90070791,EMD SERONO INC,,73.0,YR,,F,Y,97.0,KG,20190919.0,,MD,FR,FR,2019,Q3,Elderly
168308371,16830837,6,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,,,,,,, UNKNOWN,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20190809.0,20190916.0,20190920,20190920,EXP,FR-AFSSAPS-BX20191556,FR-TEVA-2019-FR-1110356,TEVA,,73.0,YR,,F,Y,97.0,KG,20190920.0,,MD,FR,FR,2019,Q3,Elderly
168308371,16830837,6,C,dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,,,,,,, UNKNOWN,,,,,,,2019,Q3,Metabolic acidosis,,2019,Q3,1,I,20190809.0,20190916.0,20190920,20190920,EXP,FR-AFSSAPS-BX20191556,FR-TEVA-2019-FR-1110356,TEVA,,73.0,YR,,F,Y,97.0,KG,20190920.0,,MD,FR,FR,2019,Q3,Elderly
168377541,16837754,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q3,Colitis,,2019,Q3,1,I,,20190918.0,20190923,20190923,EXP,,CA-TEVA-2019-CA-1112284,TEVA,,73.0,YR,,F,Y,,,20190923.0,,CN,CA,CA,2019,Q3,Elderly
168377541,16837754,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q3,Colitis ulcerative,,2019,Q3,1,I,,20190918.0,20190923,20190923,EXP,,CA-TEVA-2019-CA-1112284,TEVA,,73.0,YR,,F,Y,,,20190923.0,,CN,CA,CA,2019,Q3,Elderly
168377541,16837754,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q3,Decreased activity,,2019,Q3,1,I,,20190918.0,20190923,20190923,EXP,,CA-TEVA-2019-CA-1112284,TEVA,,73.0,YR,,F,Y,,,20190923.0,,CN,CA,CA,2019,Q3,Elderly
168377541,16837754,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q3,Frequent bowel movements,,2019,Q3,1,I,,20190918.0,20190923,20190923,EXP,,CA-TEVA-2019-CA-1112284,TEVA,,73.0,YR,,F,Y,,,20190923.0,,CN,CA,CA,2019,Q3,Elderly
168377541,16837754,17,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,7.5,MG,,/wk,2019,Q3,Rectal haemorrhage,,2019,Q3,1,I,,20190918.0,20190923,20190923,EXP,,CA-TEVA-2019-CA-1112284,TEVA,,73.0,YR,,F,Y,,,20190923.0,,CN,CA,CA,2019,Q3,Elderly
168409101,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Depression,,2019,Q3,1,I,,20190916.0,20190923,20190923,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20190923.0,,MD,DE,DE,2019,Q3,Elderly
168409101,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190916.0,20190923,20190923,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20190923.0,,MD,DE,DE,2019,Q3,Elderly
168409101,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q3,Urinary tract infection,,2019,Q3,1,I,,20190916.0,20190923,20190923,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20190923.0,,MD,DE,DE,2019,Q3,Elderly
168421031,16842103,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,20190809.0,20190909.0,20190923,20190923,EXP,,FR-AUROBINDO-AUR-APL-2019-061438,AUROBINDO,,73.0,YR,,F,Y,97.0,KG,20190924.0,,MD,FR,FR,2019,Q3,Elderly
168421031,16842103,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Metabolic acidosis,,2019,Q3,1,I,20190809.0,20190909.0,20190923,20190923,EXP,,FR-AUROBINDO-AUR-APL-2019-061438,AUROBINDO,,73.0,YR,,F,Y,97.0,KG,20190924.0,,MD,FR,FR,2019,Q3,Elderly
168436701,16843670,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,Acute kidney injury,2019,Q3,1,I,20190809.0,20190909.0,20190924,20190924,EXP,FR-AFSSAPS-BX20191556,FR-ZYDUS-040818,ZYDUS PHARM,,73.0,YR,,F,Y,97.0,KG,20190924.0,,MD,FR,FR,2019,Q3,Elderly
168436701,16843670,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q3,Metabolic acidosis,Metabolic acidosis,2019,Q3,1,I,20190809.0,20190909.0,20190924,20190924,EXP,FR-AFSSAPS-BX20191556,FR-ZYDUS-040818,ZYDUS PHARM,,73.0,YR,,F,Y,97.0,KG,20190924.0,,MD,FR,FR,2019,Q3,Elderly
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Abdominal pain,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Accidental overdose,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Diarrhoea,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Drug level increased,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Lactic acidosis,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168603211,16860321,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,1.5,G,,/wk,2019,Q3,Vomiting,,2019,Q3,1,I,20180607.0,20190711.0,20190927,20190927,EXP,FR-AFSSAPS-RE20190717,FR-EMD SERONO-E2B_90069159,EMD SERONO INC,,41.0,YR,,F,Y,100.0,KG,20190927.0,,MD,FR,FR,2019,Q3,Adult
168611911,16861191,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.7MG;?,,,Y,D,,,,,,,QW,2019,Q3,Nausea,,2019,Q3,1,I,20180828.0,,20190805,20190805,DIR,,,FDA-CTU,,70.0,YR,,M,N,89.81,KG,20190728.0,N,PH,US,US,2019,Q3,Elderly
168611911,16861191,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER DOSE:0.7MG;?,,,Y,D,,,,,,,QW,2019,Q3,Vomiting,,2019,Q3,1,I,20180828.0,,20190805,20190805,DIR,,,FDA-CTU,,70.0,YR,,M,N,89.81,KG,20190728.0,N,PH,US,US,2019,Q3,Elderly
119096845,11909684,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,U,,,,,,,,2019,Q4,Pruritus,,2019,Q4,5,F,201512.0,20160222.0,20160112,20191213,EXP,,US-UCBSA-2016000438,UCB,,39.0,YR,,F,Y,150.0,KG,20191213.0,,CN,US,US,2019,Q4,Adult
119096845,11909684,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,U,,,,,,,,2019,Q4,Sweat gland infection,,2019,Q4,5,F,201512.0,20160222.0,20160112,20191213,EXP,,US-UCBSA-2016000438,UCB,,39.0,YR,,F,Y,150.0,KG,20191213.0,,CN,US,US,2019,Q4,Adult
119096845,11909684,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,U,,,,,,,,2019,Q4,Urinary tract infection,,2019,Q4,5,F,201512.0,20160222.0,20160112,20191213,EXP,,US-UCBSA-2016000438,UCB,,39.0,YR,,F,Y,150.0,KG,20191213.0,,CN,US,US,2019,Q4,Adult
152137134,15213713,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Brain oedema,,2019,Q4,4,F,20180409.0,20191024.0,20180730,20191024,EXP,,JP-BEH-2018093214,CSL BEHRING,,77.0,YR,E,M,Y,62.6,KG,20191024.0,,MD,JP,JP,2019,Q4,Elderly
152137134,15213713,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Cerebral infarction,,2019,Q4,4,F,20180409.0,20191024.0,20180730,20191024,EXP,,JP-BEH-2018093214,CSL BEHRING,,77.0,YR,E,M,Y,62.6,KG,20191024.0,,MD,JP,JP,2019,Q4,Elderly
152137134,15213713,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Embolic stroke,,2019,Q4,4,F,20180409.0,20191024.0,20180730,20191024,EXP,,JP-BEH-2018093214,CSL BEHRING,,77.0,YR,E,M,Y,62.6,KG,20191024.0,,MD,JP,JP,2019,Q4,Elderly
152137134,15213713,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Intracardiac thrombus,,2019,Q4,4,F,20180409.0,20191024.0,20180730,20191024,EXP,,JP-BEH-2018093214,CSL BEHRING,,77.0,YR,E,M,Y,62.6,KG,20191024.0,,MD,JP,JP,2019,Q4,Elderly
152137134,15213713,14,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,4,F,20180409.0,20191024.0,20180730,20191024,EXP,,JP-BEH-2018093214,CSL BEHRING,,77.0,YR,E,M,Y,62.6,KG,20191024.0,,MD,JP,JP,2019,Q4,Elderly
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Altered state of consciousness,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Brain oedema,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Coma scale abnormal,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Dehydration,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Ketoacidosis,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
165571874,16557187,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Post procedural complication,,2019,Q4,4,F,20190704.0,20191018.0,20190711,20191021,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-029511",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,75.0,KG,20191021.0,,MD,DE,DE,2019,Q4,Adult
166766132,16676613,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,D,,,,,1.5,MG,,/wk,2019,Q4,Accidental overdose,,2019,Q4,2,F,20190503.0,20191019.0,20190807,20191024,EXP,,IT-AUROBINDO-AUR-APL-2019-044285,AUROBINDO,,47.0,YR,,F,Y,,,20191025.0,,MD,IT,IT,2019,Q4,Adult
166766132,16676613,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,D,,,,,1.5,MG,,/wk,2019,Q4,Drug interaction,,2019,Q4,2,F,20190503.0,20191019.0,20190807,20191024,EXP,,IT-AUROBINDO-AUR-APL-2019-044285,AUROBINDO,,47.0,YR,,F,Y,,,20191025.0,,MD,IT,IT,2019,Q4,Adult
166766132,16676613,3,I,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,D,,,,,1.5,MG,,/wk,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,20190503.0,20191019.0,20190807,20191024,EXP,,IT-AUROBINDO-AUR-APL-2019-044285,AUROBINDO,,47.0,YR,,F,Y,,,20191025.0,,MD,IT,IT,2019,Q4,Adult
167582212,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Arthritis,,2019,Q4,2,F,,20191025.0,20190830,20191104,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20191104.0,,MD,CZ,CZ,2019,Q4,Elderly
167582212,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,2,F,,20191025.0,20190830,20191104,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20191104.0,,MD,CZ,CZ,2019,Q4,Elderly
167582212,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Drug ineffective,,2019,Q4,2,F,,20191025.0,20190830,20191104,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20191104.0,,MD,CZ,CZ,2019,Q4,Elderly
167582212,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Hypokinesia,,2019,Q4,2,F,,20191025.0,20190830,20191104,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20191104.0,,MD,CZ,CZ,2019,Q4,Elderly
167582212,16758221,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, EVERY WEEK",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Spinal pain,,2019,Q4,2,F,,20191025.0,20190830,20191104,EXP,,CZ-AUROBINDO-AUR-APL-2019-031096,AUROBINDO,KOSKOVA M.. BENEFITS OF TREATMENT WITH DULAGLUTIDE IN A TYPE 2 DIABETES PATIENT WITH LONG-TERM UNSATISFACTORY GLYCAEMIC CONTROL. KAZUISTIKY V DIABETOLOGII. 2019;17(1):34-5,71.0,YR,,M,Y,,,20191104.0,,MD,CZ,CZ,2019,Q4,Elderly
167676651,16767665,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:EVERY 7 DAYS;?,,,N,D,,,,1.5,MG,,,2019,Q4,Rash vesicular,,2019,Q4,1,I,20190826.0,,20190903,20190903,DIR,,,FDA-CTU,,65.0,YR,,F,N,,,20190903.0,N,PH,US,US,2019,Q4,Elderly
167676651,16767665,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:EVERY 7 DAYS;?,,,N,D,,,,1.5,MG,,,2019,Q4,Stevens-Johnson syndrome,,2019,Q4,1,I,20190826.0,,20190903,20190903,DIR,,,FDA-CTU,,65.0,YR,,F,N,,,20190903.0,N,PH,US,US,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Arthritis,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Drug ineffective,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Hypertension,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Hypokinesia,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168188793,16818879,12,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MILLIGRAM, QW",,,Y,U,,,,1.5,MG,INJECTION,/wk,2019,Q4,Spinal pain,,2019,Q4,3,F,2018.0,20191211.0,20190917,20191218,EXP,,CZ-MYLANLABS-2019M1086400,MYLAN,,71.0,YR,,M,Y,,,20191218.0,,MD,CZ,CZ,2019,Q4,Elderly
168255112,16825511,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,2,F,20190809.0,20191014.0,20190919,20191021,EXP,FR-AFSSAPS-BX20191556,FR-EMD SERONO-E2B_90070791,EMD SERONO INC,,73.0,YR,,F,Y,97.0,KG,20191021.0,,MD,FR,FR,2019,Q4,Elderly
168255112,16825511,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Metabolic acidosis,,2019,Q4,2,F,20190809.0,20191014.0,20190919,20191021,EXP,FR-AFSSAPS-BX20191556,FR-EMD SERONO-E2B_90070791,EMD SERONO INC,,73.0,YR,,F,Y,97.0,KG,20191021.0,,MD,FR,FR,2019,Q4,Elderly
168409102,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Depression,,2019,Q4,2,F,,20191017.0,20190923,20191024,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20191024.0,,MD,DE,DE,2019,Q4,Elderly
168409102,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,,20191017.0,20190923,20191024,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20191024.0,,MD,DE,DE,2019,Q4,Elderly
168409102,16840910,9,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,1.5,MG,,/wk,2019,Q4,Urinary tract infection,,2019,Q4,2,F,,20191017.0,20190923,20191024,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-102640",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20191024.0,,MD,DE,DE,2019,Q4,Elderly
168871831,16887183,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Diabetic ketoacidosis,,2019,Q4,1,I,20190917.0,20191004.0,20191004,20191004,EXP,GB-MHRA-EYC 00208301,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-105953",BOEHRINGER INGELHEIM,,65.0,YR,,M,Y,,,20191004.0,,OT,GB,GB,2019,Q4,Elderly
169021773,16902177,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Parkinsonism,,2019,Q4,3,F,201812.0,20191205.0,20191010,20191219,EXP,,FR-AUROBINDO-AUR-APL-2019-065471,AUROBINDO,,65.0,YR,,M,Y,88.0,KG,20191219.0,,OT,FR,FR,2019,Q4,Elderly
169029671,16902967,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intradermal,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,,,2019,Q4,Anal incontinence,,2019,Q4,1,I,20190904.0,20190927.0,20191010,20191010,EXP,GB-MHRA-TPP15464856C5916904YC1568218130332,GB-ELI_LILLY_AND_COMPANY-GB201909014076,ELI LILLY AND CO,,48.0,YR,,M,Y,114.0,KG,20191010.0,,CN,GB,GB,2019,Q4,Adult
169029671,16902967,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intradermal,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20190904.0,20190927.0,20191010,20191010,EXP,GB-MHRA-TPP15464856C5916904YC1568218130332,GB-ELI_LILLY_AND_COMPANY-GB201909014076,ELI LILLY AND CO,,48.0,YR,,M,Y,114.0,KG,20191010.0,,CN,GB,GB,2019,Q4,Adult
169029671,16902967,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intradermal,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,,,2019,Q4,Incorrect route of product administration,,2019,Q4,1,I,20190904.0,20190927.0,20191010,20191010,EXP,GB-MHRA-TPP15464856C5916904YC1568218130332,GB-ELI_LILLY_AND_COMPANY-GB201909014076,ELI LILLY AND CO,,48.0,YR,,M,Y,114.0,KG,20191010.0,,CN,GB,GB,2019,Q4,Adult
169029671,16902967,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Intradermal,"1.5 MG, UNKNOWN",,,U,U,,,125469.0,1.5,MG,,,2019,Q4,Vomiting,,2019,Q4,1,I,20190904.0,20190927.0,20191010,20191010,EXP,GB-MHRA-TPP15464856C5916904YC1568218130332,GB-ELI_LILLY_AND_COMPANY-GB201909014076,ELI LILLY AND CO,,48.0,YR,,M,Y,114.0,KG,20191010.0,,CN,GB,GB,2019,Q4,Adult
169068111,16906811,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,G,,/wk,2019,Q4,Haemoptysis,,2019,Q4,1,I,20190719.0,20190926.0,20191011,20191011,EXP,,GB-ROCHE-2425763,ROCHE,,71.0,YR,,M,Y,117.0,KG,20191011.0,,MD,GB,GB,2019,Q4,Elderly
169068111,16906811,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,G,,/wk,2019,Q4,Pulmonary embolism,,2019,Q4,1,I,20190719.0,20190926.0,20191011,20191011,EXP,,GB-ROCHE-2425763,ROCHE,,71.0,YR,,M,Y,117.0,KG,20191011.0,,MD,GB,GB,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Acute respiratory failure,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Cardiac arrest,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Hypoxia,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Sepsis,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169169903,16916990,23,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Septic shock,,2019,Q4,3,F,20191002.0,20191016.0,20191015,20191024,EXP,,US-ROCHE-2440348,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191024.0,,MD,US,US,2019,Q4,Elderly
169228453,16922845,24,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,3,F,20191002.0,20191004.0,20191016,20191126,EXP,,US-ROCHE-2434533,ROCHE,,75.0,YR,,M,Y,120.2,KG,20191126.0,,MD,US,US,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Anxiety,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Arthralgia,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Depression,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Fatigue,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Feeling of body temperature change,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Lacrimation increased,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Night sweats,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Pain of skin,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Palpitations,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Skin burning sensation,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Suicide attempt,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Vision blurred,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169278352,16927835,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,, UNK,,,,,,,2019,Q4,Vomiting,,2019,Q4,2,F,2019.0,20191220.0,20191017,20191226,EXP,GB-MHRA-EYC 00208979,GB-ABBVIE-19K-167-2964585-00,ABBVIE,,69.0,YR,,F,Y,63.0,KG,20191226.0,,OT,GB,GB,2019,Q4,Elderly
169353101,16935310,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,?          OTHER DOSE:1.5MG;?,,,Y,D,,,,,,,QW,2019,Q4,Dehydration,,2019,Q4,1,I,20190520.0,,20190827,20190827,DIR,,,FDA-CTU,,50.0,YR,,M,N,124.0,KG,20190718.0,N,PH,US,US,2019,Q4,Adult
169353101,16935310,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,?          OTHER DOSE:1.5MG;?,,,Y,D,,,,,,,QW,2019,Q4,Nausea,,2019,Q4,1,I,20190520.0,,20190827,20190827,DIR,,,FDA-CTU,,50.0,YR,,M,N,124.0,KG,20190718.0,N,PH,US,US,2019,Q4,Adult
169353101,16935310,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,?          OTHER DOSE:1.5MG;?,,,Y,D,,,,,,,QW,2019,Q4,Palpitations,,2019,Q4,1,I,20190520.0,,20190827,20190827,DIR,,,FDA-CTU,,50.0,YR,,M,N,124.0,KG,20190718.0,N,PH,US,US,2019,Q4,Adult
169353101,16935310,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,?          OTHER DOSE:1.5MG;?,,,Y,D,,,,,,,QW,2019,Q4,Vomiting,,2019,Q4,1,I,20190520.0,,20190827,20190827,DIR,,,FDA-CTU,,50.0,YR,,M,N,124.0,KG,20190718.0,N,PH,US,US,2019,Q4,Adult
169403942,16940394,6,C,Dulaglutide ((MAMMIFERE/HAMSTER/CELLULES CHO)),,2,Unknown,(),,,,,,,,,,,,2019,Q4,Parkinsonism,,2019,Q4,2,F,201812.0,20191210.0,20191021,20191223,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-224321,RANBAXY,,65.0,YR,,M,Y,88.0,KG,20191223.0,,OT,NL,FR,2019,Q4,Elderly
169532351,16953235,1,PS,Dulaglutide 0.75mg,DULAGLUTIDE,1,Unknown,0.75 MG,,,U,U,,,125469.0,0.75,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q4,Dehydration,,2019,Q4,1,I,20190927.0,20191014.0,20191023,20191023,EXP,GB-MHRA-TPP33269947C6908655YC1569598337490,GB-ELI_LILLY_AND_COMPANY-GB201910007197,ELI LILLY AND CO,,56.0,YR,,F,Y,116.0,KG,20191023.0,,CN,GB,GB,2019,Q4,Adult
169532351,16953235,1,PS,Dulaglutide 0.75mg,DULAGLUTIDE,1,Unknown,0.75 MG,,,U,U,,,125469.0,0.75,MG,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2019,Q4,Vomiting,,2019,Q4,1,I,20190927.0,20191014.0,20191023,20191023,EXP,GB-MHRA-TPP33269947C6908655YC1569598337490,GB-ELI_LILLY_AND_COMPANY-GB201910007197,ELI LILLY AND CO,,56.0,YR,,F,Y,116.0,KG,20191023.0,,CN,GB,GB,2019,Q4,Adult
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Anxiety,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Arthralgia,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Fatigue,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Feeling of body temperature change,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Lacrimation increased,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Night sweats,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Pain,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Palpitations,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Skin burning sensation,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Suicide attempt,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Vision blurred,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169571981,16957198,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,20190623.0,20191017.0,20191024,20191024,PER,,GB-AMGEN-GBRSP2019173606,AMGEN,,69.0,YR,E,F,Y,63.0,KG,20191024.0,,OT,GB,GB,2019,Q4,Elderly
169647191,16964719,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 G, WEEKLY",,,,,,,,1.5,G,,/wk,2019,Q4,Haemoptysis,,2019,Q4,1,I,20190719.0,20191022.0,20191028,20191028,EXP,,GB-PFIZER INC-2019457509,PFIZER,,71.0,YR,,M,Y,117.0,KG,20191028.0,,MD,GB,GB,2019,Q4,Elderly
169647191,16964719,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 G, WEEKLY",,,,,,,,1.5,G,,/wk,2019,Q4,Pulmonary embolism,,2019,Q4,1,I,20190719.0,20191022.0,20191028,20191028,EXP,,GB-PFIZER INC-2019457509,PFIZER,,71.0,YR,,M,Y,117.0,KG,20191028.0,,MD,GB,GB,2019,Q4,Elderly
169914794,16991479,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,1.5 MILLIGRAM,,,,,,,,1.5,MG,UNKNOWN,/wk,2019,Q4,Arthritis bacterial,,2019,Q4,4,F,20191024.0,20191203.0,20191104,20191205,EXP,,AU-CELGENEUS-AUS-20191011603,CELGENE,,65.0,YR,,M,Y,168.0,KG,20191205.0,,MD,AU,AU,2019,Q4,Elderly
169924401,16992440,2,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,1.5MG/0.5ML,,,,,,,,1.0,DF,SOLN FOR INJECT IN PRE-FILLED SYRINGE,/wk,2019,Q4,Urinary retention,,2019,Q4,1,I,20180409.0,20191030.0,20191105,20191105,EXP,GB-MHRA-ADR 24315162,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-110945",BOEHRINGER INGELHEIM,,53.0,YR,,M,Y,126.0,KG,20191105.0,,MD,GB,GB,2019,Q4,Adult
169927161,16992716,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,,2019,Q4,Arthritis,,2019,Q4,1,I,,20190727.0,20191105,20191105,EXP,CZ-EMA-DD-20190726-BANAVALLI_M-122036,CZ-ACCORD-149908,ACCORD,,71.0,YR,,M,Y,,,20191105.0,,MD,CZ,CZ,2019,Q4,Elderly
169927161,16992716,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,,20190727.0,20191105,20191105,EXP,CZ-EMA-DD-20190726-BANAVALLI_M-122036,CZ-ACCORD-149908,ACCORD,,71.0,YR,,M,Y,,,20191105.0,,MD,CZ,CZ,2019,Q4,Elderly
169927161,16992716,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,1,I,,20190727.0,20191105,20191105,EXP,CZ-EMA-DD-20190726-BANAVALLI_M-122036,CZ-ACCORD-149908,ACCORD,,71.0,YR,,M,Y,,,20191105.0,,MD,CZ,CZ,2019,Q4,Elderly
169927161,16992716,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,,2019,Q4,Hypokinesia,,2019,Q4,1,I,,20190727.0,20191105,20191105,EXP,CZ-EMA-DD-20190726-BANAVALLI_M-122036,CZ-ACCORD-149908,ACCORD,,71.0,YR,,M,Y,,,20191105.0,,MD,CZ,CZ,2019,Q4,Elderly
169927161,16992716,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW",,,Y,,,,,1.5,MG,INJECTION,,2019,Q4,Spinal pain,,2019,Q4,1,I,,20190727.0,20191105,20191105,EXP,CZ-EMA-DD-20190726-BANAVALLI_M-122036,CZ-ACCORD-149908,ACCORD,,71.0,YR,,M,Y,,,20191105.0,,MD,CZ,CZ,2019,Q4,Elderly
169970231,16997023,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2019,Q4,Nausea,,2019,Q4,1,I,20190903.0,,20190923,20190923,DIR,,,FDA-CTU,,47.0,YR,,M,N,154.0,KG,20190906.0,N,PH,US,US,2019,Q4,Adult
169970231,16997023,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2019,Q4,Pancreatitis,,2019,Q4,1,I,20190903.0,,20190923,20190923,DIR,,,FDA-CTU,,47.0,YR,,M,N,154.0,KG,20190906.0,N,PH,US,US,2019,Q4,Adult
169970231,16997023,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2019,Q4,Vomiting,,2019,Q4,1,I,20190903.0,,20190923,20190923,DIR,,,FDA-CTU,,47.0,YR,,M,N,154.0,KG,20190906.0,N,PH,US,US,2019,Q4,Adult
170018501,17001850,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW, DRUG WITHDRAWN",,,U,,,,,1.5,MG,INJECTION,/wk,2019,Q4,Arthritis,,2019,Q4,1,I,201902.0,20190801.0,20191106,20191106,EXP,,CZ-SA-2019SA211227,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20191107.0,,OT,CZ,CZ,2019,Q4,Elderly
170018501,17001850,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW, DRUG WITHDRAWN",,,U,,,,,1.5,MG,INJECTION,/wk,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,201902.0,20190801.0,20191106,20191106,EXP,,CZ-SA-2019SA211227,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20191107.0,,OT,CZ,CZ,2019,Q4,Elderly
170018501,17001850,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW, DRUG WITHDRAWN",,,U,,,,,1.5,MG,INJECTION,/wk,2019,Q4,Drug ineffective,,2019,Q4,1,I,201902.0,20190801.0,20191106,20191106,EXP,,CZ-SA-2019SA211227,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20191107.0,,OT,CZ,CZ,2019,Q4,Elderly
170018501,17001850,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW, DRUG WITHDRAWN",,,U,,,,,1.5,MG,INJECTION,/wk,2019,Q4,Hypokinesia,,2019,Q4,1,I,201902.0,20190801.0,20191106,20191106,EXP,,CZ-SA-2019SA211227,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20191107.0,,OT,CZ,CZ,2019,Q4,Elderly
170018501,17001850,11,C,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, QW, DRUG WITHDRAWN",,,U,,,,,1.5,MG,INJECTION,/wk,2019,Q4,Spinal pain,,2019,Q4,1,I,201902.0,20190801.0,20191106,20191106,EXP,,CZ-SA-2019SA211227,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20191107.0,,OT,CZ,CZ,2019,Q4,Elderly
170024031,17002403,5,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,1.5,MG,,,,,,1.5,MG,,/wk,2019,Q4,Candida infection,,2019,Q4,1,I,20180731.0,20191031.0,20191107,20191107,EXP,GB-MHRA-TPP10727181C4768372YC1533041612073,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-111191",BOEHRINGER INGELHEIM,,61.0,YR,,M,Y,104.0,KG,20191107.0,,PH,GB,GB,2019,Q4,Adult
170056711,17005671,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2019,Q4,Dehydration,,2019,Q4,1,I,201705.0,20171102.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201711001094,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20191107.0,,CN,US,US,2019,Q4,Adult
170056711,17005671,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2019,Q4,Food poisoning,,2019,Q4,1,I,201705.0,20171102.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201711001094,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20191107.0,,CN,US,US,2019,Q4,Adult
170056711,17005671,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2019,Q4,Genital infection fungal,,2019,Q4,1,I,201705.0,20171102.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201711001094,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20191107.0,,CN,US,US,2019,Q4,Adult
170056711,17005671,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2019,Q4,Oral fungal infection,,2019,Q4,1,I,201705.0,20171102.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201711001094,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20191107.0,,CN,US,US,2019,Q4,Adult
170056711,17005671,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,U,,,125469.0,,,INJECTION,,2019,Q4,Product dose omission,,2019,Q4,1,I,201705.0,20171102.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201711001094,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20191107.0,,CN,US,US,2019,Q4,Adult
170278091,17027809,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U, D071431C,,125469.0,,,INJECTION,,2019,Q4,Drug hypersensitivity,,2019,Q4,1,I,,20191101.0,20191113,20191113,EXP,,US-ELI_LILLY_AND_COMPANY-US201911000929,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20191113.0,,CN,US,US,2019,Q4,Elderly
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Cellulitis,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Drug titration error,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Limb injury,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Nausea,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170509041,17050904,8,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MILLIGRAM, EVERY WEEK",,,U,,,,,1.5,MG,,/wk,2019,Q4,Oedema peripheral,,2019,Q4,1,I,,20191108.0,20191120,20191120,EXP,,CA-AUROBINDO-AUR-APL-2019-073755,AUROBINDO,,48.0,YR,,M,Y,151.0,KG,20191120.0,,OT,CA,CA,2019,Q4,Adult
170615531,17061553,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170615531,17061553,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170615531,17061553,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170616461,17061646,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",42.214,MG,N,U,,,125469.0,1.5,MG,,/wk,2019,Q4,Abdominal pain upper,,2019,Q4,1,I,20191023.0,20191113.0,20191121,20191121,EXP,GB-MHRA-EYC 00211232,GB-ELI_LILLY_AND_COMPANY-GB201911006542,ELI LILLY AND CO,,85.0,YR,,M,Y,84.6,KG,20191121.0,,CN,GB,GB,2019,Q4,Elderly
170616461,17061646,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",42.214,MG,N,U,,,125469.0,1.5,MG,,/wk,2019,Q4,Cholecystitis acute,,2019,Q4,1,I,20191023.0,20191113.0,20191121,20191121,EXP,GB-MHRA-EYC 00211232,GB-ELI_LILLY_AND_COMPANY-GB201911006542,ELI LILLY AND CO,,85.0,YR,,M,Y,84.6,KG,20191121.0,,CN,GB,GB,2019,Q4,Elderly
170616461,17061646,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"1.5 MG, WEEKLY (1/W)",42.214,MG,N,U,,,125469.0,1.5,MG,,/wk,2019,Q4,Liver function test abnormal,,2019,Q4,1,I,20191023.0,20191113.0,20191121,20191121,EXP,GB-MHRA-EYC 00211232,GB-ELI_LILLY_AND_COMPANY-GB201911006542,ELI LILLY AND CO,,85.0,YR,,M,Y,84.6,KG,20191121.0,,CN,GB,GB,2019,Q4,Elderly
170831041,17083104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2019,Q4,Cholelithiasis,,2019,Q4,1,I,,20191118.0,20191127,20191127,EXP,,US-ELI_LILLY_AND_COMPANY-US201911008200,ELI LILLY AND CO,,59.0,YR,,,Y,,,20191127.0,,CN,US,US,2019,Q4,Adult
170831041,17083104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2019,Q4,Pancreatitis,,2019,Q4,1,I,,20191118.0,20191127,20191127,EXP,,US-ELI_LILLY_AND_COMPANY-US201911008200,ELI LILLY AND CO,,59.0,YR,,,Y,,,20191127.0,,CN,US,US,2019,Q4,Adult
170831041,17083104,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,U,U,,,125469.0,,,INJECTION,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191118.0,20191127,20191127,EXP,,US-ELI_LILLY_AND_COMPANY-US201911008200,ELI LILLY AND CO,,59.0,YR,,,Y,,,20191127.0,,CN,US,US,2019,Q4,Adult
170874462,17087446,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,,,,,0.75,MG,INJECTION,,2019,Q4,Cardiac failure,,2019,Q4,2,F,,20191218.0,20191128,20191223,EXP,,US-ELI_LILLY_AND_COMPANY-US201911011964,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20191223.0,,CN,US,US,2019,Q4,Elderly
170874462,17087446,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,"0.75 MG, UNKNOWN",,,,, D131484D,,,0.75,MG,INJECTION,,2019,Q4,Cardiac failure,,2019,Q4,2,F,,20191218.0,20191128,20191223,EXP,,US-ELI_LILLY_AND_COMPANY-US201911011964,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20191223.0,,CN,US,US,2019,Q4,Elderly
170876721,17087672,27,C,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,U,,,,,,,,2019,Q4,Rheumatoid arthritis,,2019,Q4,1,I,201806.0,20180725.0,20191128,20191128,PER,,US-UCBSA-2018033678,UCB,,75.0,YR,,M,Y,,,20191128.0,,PH,US,US,2019,Q4,Elderly
170912721,17091272,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,D,D,,,,,,,,2019,Q4,Injection site pain,,2019,Q4,1,I,20190814.0,,20191031,20191031,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20191017.0,N,PH,US,US,2019,Q4,Elderly
171040261,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171040261,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171040261,17104026,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171042231,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2019,Q4,Injection site erythema,,2019,Q4,1,I,2017.0,20171127.0,20191203,20191203,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20191203.0,,PH,US,US,2019,Q4,Adult
171042231,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2019,Q4,Injection site reaction,,2019,Q4,1,I,2017.0,20171127.0,20191203,20191203,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20191203.0,,PH,US,US,2019,Q4,Adult
171042231,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2019,Q4,Off label use,,2019,Q4,1,I,2017.0,20171127.0,20191203,20191203,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20191203.0,,PH,US,US,2019,Q4,Adult
171042231,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2019,Q4,Pain,,2019,Q4,1,I,2017.0,20171127.0,20191203,20191203,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20191203.0,,PH,US,US,2019,Q4,Adult
171042231,17104223,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2019,Q4,Psoriasis,,2019,Q4,1,I,2017.0,20171127.0,20191203,20191203,PER,,US-UCBSA-2017048530,UCB,,47.0,YR,,M,Y,,,20191203.0,,PH,US,US,2019,Q4,Adult
171370431,17137043,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, WEEKLY",,,,,,,,7.5,MG,,/wk,2019,Q4,Colitis,,2019,Q4,1,I,,20191205.0,20191210,20191210,EXP,,CA-PFIZER INC-2019528982,PFIZER,,73.0,YR,,F,Y,,,20191210.0,,CN,CA,CA,2019,Q4,Elderly
171370431,17137043,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, WEEKLY",,,,,,,,7.5,MG,,/wk,2019,Q4,Colitis ulcerative,,2019,Q4,1,I,,20191205.0,20191210,20191210,EXP,,CA-PFIZER INC-2019528982,PFIZER,,73.0,YR,,F,Y,,,20191210.0,,CN,CA,CA,2019,Q4,Elderly
171370431,17137043,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, WEEKLY",,,,,,,,7.5,MG,,/wk,2019,Q4,Decreased activity,,2019,Q4,1,I,,20191205.0,20191210,20191210,EXP,,CA-PFIZER INC-2019528982,PFIZER,,73.0,YR,,F,Y,,,20191210.0,,CN,CA,CA,2019,Q4,Elderly
171370431,17137043,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, WEEKLY",,,,,,,,7.5,MG,,/wk,2019,Q4,Frequent bowel movements,,2019,Q4,1,I,,20191205.0,20191210,20191210,EXP,,CA-PFIZER INC-2019528982,PFIZER,,73.0,YR,,F,Y,,,20191210.0,,CN,CA,CA,2019,Q4,Elderly
171370431,17137043,16,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MG, WEEKLY",,,,,,,,7.5,MG,,/wk,2019,Q4,Rectal haemorrhage,,2019,Q4,1,I,,20191205.0,20191210,20191210,EXP,,CA-PFIZER INC-2019528982,PFIZER,,73.0,YR,,F,Y,,,20191210.0,,CN,CA,CA,2019,Q4,Elderly
171517772,17151777,11,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,Y,U,,,,,,INJECTION,,2019,Q4,Abdominal adhesions,,2019,Q4,2,F,20191201.0,20191216.0,20191213,20191220,EXP,,GB-MYLANLABS-2019M1122299,MYLAN,,69.0,YR,,F,Y,,,20191220.0,,MD,GB,GB,2019,Q4,Elderly
171517772,17151777,11,SS,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,Y,U,,,,,,INJECTION,,2019,Q4,Small intestinal obstruction,,2019,Q4,2,F,20191201.0,20191216.0,20191213,20191220,EXP,,GB-MYLANLABS-2019M1122299,MYLAN,,69.0,YR,,F,Y,,,20191220.0,,MD,GB,GB,2019,Q4,Elderly
171621491,17162149,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U,,,,,,,,2019,Q4,Cardiac amyloidosis,,2019,Q4,1,I,,20191210.0,20191217,20191217,EXP,,"US-LEADING PHARMA, LLC-2077882",LEADING PHARMA,"PATEL SN, KOYODA SK, SCHWARTZ D, AYESHA B. SEVERE HAND PAIN AS AN EXTRACARDIAC MANIFESTATION OF TRANSTHYRETIN?AMYLOIDOSIS. BMJ CASE REPORT 2019; 12: E229677. DOI: 10.1136/BCR-2019-229677",73.0,YR,,F,Y,,,20191217.0,,OT,US,US,2019,Q4,Elderly
171621491,17162149,7,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,U,U,,,,,,,,2019,Q4,Gout,,2019,Q4,1,I,,20191210.0,20191217,20191217,EXP,,"US-LEADING PHARMA, LLC-2077882",LEADING PHARMA,"PATEL SN, KOYODA SK, SCHWARTZ D, AYESHA B. SEVERE HAND PAIN AS AN EXTRACARDIAC MANIFESTATION OF TRANSTHYRETIN?AMYLOIDOSIS. BMJ CASE REPORT 2019; 12: E229677. DOI: 10.1136/BCR-2019-229677",73.0,YR,,F,Y,,,20191217.0,,OT,US,US,2019,Q4,Elderly
171633631,17163363,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,,,,,,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,20190920.0,,20191124,20191124,DIR,,,FDA-CTU,,77.0,YR,,M,N,,,20191118.0,N,PH,US,US,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Anxiety,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Arthralgia,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Fatigue,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Feeling of body temperature change,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Lacrimation increased,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Night sweats,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Pain,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Palpitations,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Skin burning sensation,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Suicide attempt,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Vision blurred,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171731801,17173180,4,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,20190623.0,20191206.0,20191218,20191218,EXP,GB-MHRA-EYC 00208979,NVSC2019GB062869,NOVARTIS,,69.0,YR,,F,Y,63.0,KG,20191219.0,,OT,GB,GB,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Abdominal discomfort,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Asthenia,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Chills,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Decreased appetite,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Fatigue,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Feeding disorder,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Hyperhidrosis,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Nausea,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Retching,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Somnolence,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171826801,17182680,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"0.75 MG, UNKNOWN",,,U,U, D071429D,,125469.0,0.75,MG,INJECTION,,2019,Q4,Weight decreased,,2019,Q4,1,I,20191205.0,20191210.0,20191220,20191220,EXP,,US-ELI_LILLY_AND_COMPANY-US201912005089,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191220.0,,CN,US,US,2019,Q4,Elderly
171890441,17189044,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,USE AS DIRECTED,,,,,,,,,,,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191202.0,20191216.0,20191223,20191223,EXP,GB-MHRA-TPP791403C2190988YC1575297733928,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-120450",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,87.0,KG,20191223.0,,OT,GB,GB,2019,Q4,Elderly
171890441,17189044,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,USE AS DIRECTED,,,,,,,,,,,,2019,Q4,Malaise,,2019,Q4,1,I,20191202.0,20191216.0,20191223,20191223,EXP,GB-MHRA-TPP791403C2190988YC1575297733928,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-120450",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,87.0,KG,20191223.0,,OT,GB,GB,2019,Q4,Elderly
171890441,17189044,3,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,USE AS DIRECTED,,,,,,,,,,,,2019,Q4,Thirst,,2019,Q4,1,I,20191202.0,20191216.0,20191223,20191223,EXP,GB-MHRA-TPP791403C2190988YC1575297733928,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-120450",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,87.0,KG,20191223.0,,OT,GB,GB,2019,Q4,Elderly
171907621,17190762,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,,2019,Q4,Angioedema,,2019,Q4,1,I,20191220.0,,20191220,20191220,DIR,,,FDA-CTU,,52.0,YR,,F,N,89.0,KG,20191220.0,N,PH,US,US,2019,Q4,Adult
171907621,17190762,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,0.75,MG,,,2019,Q4,Neck pain,,2019,Q4,1,I,20191220.0,,20191220,20191220,DIR,,,FDA-CTU,,52.0,YR,,F,N,89.0,KG,20191220.0,N,PH,US,US,2019,Q4,Adult
171961151,17196115,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,,U,,,125469.0,1.5,MG,INJECTION,/wk,2019,Q4,Abdominal pain upper,,2019,Q4,1,I,,20191218.0,20191224,20191224,EXP,,RU-ELI_LILLY_AND_COMPANY-RU201912010627,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191224.0,,CN,RU,RU,2019,Q4,Adult
171961151,17196115,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,,U,,,125469.0,1.5,MG,INJECTION,/wk,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191218.0,20191224,20191224,EXP,,RU-ELI_LILLY_AND_COMPANY-RU201912010627,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191224.0,,CN,RU,RU,2019,Q4,Adult
171961151,17196115,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,,U,,,125469.0,1.5,MG,INJECTION,/wk,2019,Q4,Seizure,,2019,Q4,1,I,,20191218.0,20191224,20191224,EXP,,RU-ELI_LILLY_AND_COMPANY-RU201912010627,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191224.0,,CN,RU,RU,2019,Q4,Adult
171961151,17196115,1,PS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"1.5 MG, WEEKLY (1/W)",,,,U,,,125469.0,1.5,MG,INJECTION,/wk,2019,Q4,Syncope,,2019,Q4,1,I,,20191218.0,20191224,20191224,EXP,,RU-ELI_LILLY_AND_COMPANY-RU201912010627,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191224.0,,CN,RU,RU,2019,Q4,Adult
172018881,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2019,Q4,Colitis,,2019,Q4,1,I,,20191216.0,20191226,20191226,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20191226.0,,CN,CA,CA,2019,Q4,Elderly
172018881,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2019,Q4,Colitis ulcerative,,2019,Q4,1,I,,20191216.0,20191226,20191226,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20191226.0,,CN,CA,CA,2019,Q4,Elderly
172018881,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2019,Q4,Decreased activity,,2019,Q4,1,I,,20191216.0,20191226,20191226,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20191226.0,,CN,CA,CA,2019,Q4,Elderly
172018881,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2019,Q4,Frequent bowel movements,,2019,Q4,1,I,,20191216.0,20191226,20191226,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20191226.0,,CN,CA,CA,2019,Q4,Elderly
172018881,17201888,18,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,"7.5 MILLIGRAM, QW",,,,,,,,7.5,MG,,/wk,2019,Q4,Rectal haemorrhage,,2019,Q4,1,I,,20191216.0,20191226,20191226,EXP,,CA-MYLANLABS-2019M1126389,MYLAN,,73.0,YR,,F,Y,,,20191226.0,,CN,CA,CA,2019,Q4,Elderly
172093271,17209327,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,20190809.0,20191219.0,20191227,20191227,EXP,FR-AFSSAPS-BX20191556,FR-MYLANLABS-2019M1128019,MYLAN,,73.0,YR,,F,Y,97.0,KG,20191227.0,,MD,FR,FR,2019,Q4,Elderly
172093271,17209327,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,,UNK,,,,,,,,,,,,2019,Q4,Metabolic acidosis,,2019,Q4,1,I,20190809.0,20191219.0,20191227,20191227,EXP,FR-AFSSAPS-BX20191556,FR-MYLANLABS-2019M1128019,MYLAN,,73.0,YR,,F,Y,97.0,KG,20191227.0,,MD,FR,FR,2019,Q4,Elderly
172116431,17211643,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,,,INJECTION,,2019,Q4,Abdominal adhesions,,2019,Q4,1,I,20191201.0,20191224.0,20191229,20191229,EXP,,GB-JNJFOC-20191240600,JOHNSON AND JOHNSON,,69.0,YR,,F,Y,,,20191229.0,,MD,GB,GB,2019,Q4,Elderly
172116431,17211643,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,Y,,,,,,,INJECTION,,2019,Q4,Small intestinal obstruction,,2019,Q4,1,I,20191201.0,20191224.0,20191229,20191229,EXP,,GB-JNJFOC-20191240600,JOHNSON AND JOHNSON,,69.0,YR,,F,Y,,,20191229.0,,MD,GB,GB,2019,Q4,Elderly
172155191,17215519,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,INJECTION,,2019,Q4,Abdominal adhesions,,2019,Q4,1,I,20191201.0,20191224.0,20191230,20191230,EXP,,GB-OTSUKA-2019_042732,OTSUKA,,69.0,YR,,F,Y,,,20191230.0,,MD,GB,GB,2019,Q4,Elderly
172155191,17215519,2,SS,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,INJECTION,,2019,Q4,Small intestinal obstruction,,2019,Q4,1,I,20191201.0,20191224.0,20191230,20191230,EXP,,GB-OTSUKA-2019_042732,OTSUKA,,69.0,YR,,F,Y,,,20191230.0,,MD,GB,GB,2019,Q4,Elderly
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood electrolytes abnormal,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Confusional state,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Dehydration,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Euglycaemic diabetic ketoacidosis,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172167231,17216723,6,C,DULAGLUTIDE.,DULAGLUTIDE,1,Unknown,,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,20191215.0,20191227.0,20191230,20191230,EXP,GB-MHRA-EYC 00214954,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-122433",BOEHRINGER INGELHEIM,,54.0,YR,,F,Y,,,20191231.0,,PH,GB,GB,2019,Q4,Adult
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Abdominal pain upper,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Cholecystitis,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Cholecystitis infective,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Decreased appetite,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Murphy's sign positive,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172252711,17225271,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,D,, C941631,20200131.0,,1.5,MG,,QW,2019,Q4,Nausea,,2019,Q4,1,I,20190924.0,,20191209,20191209,DIR,,,FDA-CTU,,72.0,YR,,M,N,108.0,KG,20191119.0,N,PH,US,US,2019,Q4,Elderly
172256101,17225610,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2019,Q4,Abdominal distension,,2019,Q4,1,I,20190308.0,,20191209,20191209,DIR,,,FDA-CTU,,55.0,YR,,M,N,120.66,KG,20191129.0,N,PH,US,US,2019,Q4,Adult
172256101,17225610,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,20190308.0,,20191209,20191209,DIR,,,FDA-CTU,,55.0,YR,,M,N,120.66,KG,20191129.0,N,PH,US,US,2019,Q4,Adult
172256101,17225610,1,PS,"DULAGLUTIDE (DULAGLUTIDE 1.5MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,,,,,,,,,,1.5,MG,,,2019,Q4,Pancreatitis acute,,2019,Q4,1,I,20190308.0,,20191209,20191209,DIR,,,FDA-CTU,,55.0,YR,,M,N,120.66,KG,20191129.0,N,PH,US,US,2019,Q4,Adult
172295271,17229527,1,PS,"DULAGLUTIDE (DULAGLUTIDE 0.75MG/0.5ML INJ, SOLN PEN)",DULAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.75,MG,,QW,2019,Q4,Pancreatitis,,2019,Q4,1,I,20180416.0,,20191210,20191210,DIR,,,FDA-CTU,,65.0,YR,,M,N,93.17,KG,20180618.0,N,OT,US,US,2019,Q4,Elderly
